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ABSTRACT
DESIGN OF IN VIVO ASSAYS FOR STUDY OF TRANSPORT,
BIOCOMPATIBLITY AND TOXICITY OF NANOPARTICLES
Kerry Jean Lee
Old Dominion University, 2012
Director: Dr. Xiao-Hong Nancy Xu

This dissertation focuses on the design of new in vivo assays for study of
transport, biocompatibility and toxicity of nanoparticles (NPs) in zebrafish
embryos. We synthesized and purified spherical silver (Ag) NPs with diameters,
ranging from 12 to 95 nm, that are stable (non-aggregated) in egg-water media.
We developed new imaging approaches to characterize the sizes of single Ag
NPs in zebrafish embryos at nanometer resolution by measuring their sizedependent plasmonic spectra and scattering intensity using dark-field optical
microscopy and spectroscopy (DFOMS). We used single Ag NPs because they
exhibit the high quantum yield (QY) of Rayleigh scattering and resist
photobleaching and blinking, allowing to be continuously monitored in vivo for any
desired amount of time. These unique optical properties make them better than
traditional imaging probes, such as fluorescence probes (e.g., fluorophores and
semiconductor quantum dots), that are currently used for in vivo imaging and
widely used in life science. With no need of fluorescence excitation, Ag NPs can
be used to monitor transport in a living in vivo system and effectively avoids autofluorescence of the living organism, allowing us to monitor it in real-time in the
developing embryo.
Using different properties of Ag NPs, size-dependent optical properties
and charge-dependent surface properties, we studied transport and toxicity in
living embryos in real-time for better understanding of biocompatibility of NPs in a
living in vivo model system. Using Ag NPs, we continuously imaged nanoenvironments of developing zebrafish embryos for hours and discovered their
transport patterns through the chorion and into the chorion space of the different
stages of embryos. We demonstrated that the different types of Ag NPs caused
a wide variety of deformities and caused an increase in death, and both in a
concentration dependent manner in living zebrafish embryos. This determined
that zebrafish embryos are a powerful in vivo assay to use to study the transport,
biocompatibility and toxicity of nanomaterials.
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NOMENCLATURE

Extinction coefficient
MQ/mL

Microgram per milliliter

pm

Micrometer

*n

Viscosity
Zeta potential in mV

Ag

Silver

AgCI04

Silver perchlorate

Ag-CALNNE

Silver nanoparticles functionalized with CALNNE peptide
yielding a negative charge

Ag-CALNNK

Silver nanoparticles functionalized with CALNNK peptide
yielding a positive charge

Ag-CALNNS

Silver nanoparticles functionalized with CALNNS peptide
yielding a near neutral charge

AgN03

Silver nitrate

cm

centimeter

C

Concentration

CASI

Color as a size index

CCD

Charge coupled device used for imaging nanoparticles with
high sensitivity, temporal resolution and spatial resolution

Cd2+

Cadmium

CL

Chorion Layer

CPCs

Chorion Pore Channels

CS

Chorion space
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D

Diffusion coefficient

DCA

Dichloroacetic acid

DFOM

Dark field optical microscopy

DFOMS

Dark field optical microscopy and spectroscopy

Dl

De-ionized

DLS

Dynamic light scattering

DNA

Deoxyribonucleic acid

EM

Electron microscopy

EMCCD

Electron multiplying charge coupled device

FWHM

Full width at half maxima

h

Hour

H202

Hydrogen peroxide

hpf

Hours post fertilization

HRTEM

High resolution transmission electron microscopy

IME

Inner mass of embryo

K

Boltzman Constant

LSPR

Localized surface plasmon resonance

mm

Millimeter

MSD

mean-squared-displacement

MSI

Multi-spectral imaging

mV

Millivolt

nM

Nanomolar

rim

Nanometer

NaBH4

Sodium tetrahydroBoride

NaCI

Sodium chloride

NPs

Nanoparticles

OC

Outside chorion

pM

Picomolar

QDs

Quantum dots

QY

Quantum yield

RTSD

Real-time-squared-displacement

SEM

Scanning electron microscopy

SMD

Single molecule detection

SPR

Surface plasmon resonance

T

Temperature in kelvin

TCDD

2, 3, 7, 8 - tetrachlorodibenzo-p-dioxin

TEM

Transmission electron microscopy

UV-vis

Ultraviolet- visible

W

Watt

WT

Wild type

YS

Yolk sac
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CHAPTER I
OVERVIEW
Nanomaterials possess unique physical and surface properties, which
have inspired plans for a wide spectrum of applications, such as target-specific
vehicles for in vivo sensing, diagnosis, and therapy (e.g., nanomedicine, drug
delivery).1"5 These unique properties may also incite toxicity, damaging in vivo
systems of interest and posing risks to human health and the environment.6
Therefore, our primary focus was to probe the transport in real-time and
concentration-dependent biocompatibility and toxicity of NPs in an in vivo model
system and demonstrate the possibility of creating an in vivo assay using
zebrafish embryos as a standard to study the biocompatibility and toxicity of
nanomaterials. Establishing an in vivo assay enables the screening of NPs and
determines their prospective use in a living system and the side effects caused
by their exposure. Studying the transport and biocompatibility of NPs in real-time
during early embryonic development will provide new information into the
transport mechanisms and the interactions of NPs with the developing embryos.
Different types of NPs have not yet been assessed for their biocompatibility and
toxicity in an in vivo model system, so it is important to investigate the effects of
their exposure. Hence, it is important to develop an in vivo assay to efficiently
screen the biocompatibility and toxicity of NPs in real-time while investigating the
transport mechanism.
We used silver (Ag) NPs as our model nanomaterials to study transport
and biocompatibility in a developing embryo model system.

The reason we

choose to use Ag NPs is because noble metal NPs possess unique optical
properties, such as, localized-surface-plasmon resonance (LSPR), which
dependent upon their size and shape. This allows them to be directly imaged in
the living system without any fluorescence excitation3,7"9. Fluorescent dyes are a
preference as probes for in vivo imaging, but these are obsolete because most
fluorescence dyes suffer from photodecomposition and cannot be followed for a

The journal for this dissertation is ACS Nano
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long period of time during development10. Noble metal NPs, such as Ag NPs,
have been shown to be photostable and do not demonstrate photobleaching or
photoblinking enabling them to be used as important and powerful imaging tool11"
15.

Silver NPs are extremely bright and can be directly observed and imaged

using dark field optical microscopy and spectroscopy (DFOMS).

Unlike

fluorescent probes and quantum dots, noble metal NPs do not suffer
photodecomposition or photoblinking and can be used as a probe to continuously
monitor dynamic events for an extended period of time. Moreover, the LSPR
spectra of nanoparticles shows size dependence, thus one can use the color
(LSPR spectra) index of these multicolor nanoparticles as a nanometer size
index to directly measure membrane transports of nanoparticles and determine
the size of membrane pores at the nanometer scale in real-time14,

15.

Size is

important because it influences every aspect of nanoparticle function, including
uptake mechanisms and nanoparticle clearance.
Zebrafish embryos were the in vivo model system of choice because they
have characteristic beneficial features over other vertebrate model systems, such
as the mouse, rat, and human.

For example, zebrafish development is

completed within 120 h and the stages are well documented.16"20 Additionally,
zebrafish embryos develop outside of their mothers and are transparent, which
makes them easy to see and observe allowing for direct observation of normal,
dead, deformed embryos. Zebrafish also share similarities to human genes and
diseases, and the protein sequences of drug-binding receptors in zebrafish and
humans show a high degree of affinity.16,20 Thus, zebrafish are an important in
vivo model system for screening drugs for use against human diseases. Lastly,
zebrafish are ideal because they generate many embryos fast and at minimal
cost, which is an important factor for establishing an efficient and affordable in
vivo assay for the screening of biocompatibility of different types of NPs.
The zebrafish as an in vivo model system has become commonplace for
screening chemical toxicity17 and drug biocompatibility20, but it has not been used
for the screening of biocompatibility and toxicity of NPs. Furthermore, in all

3

reported nanotoxicity studies, conventional toxicological assays were primarily
used, which cannot characterize dose of nanoparticles in vivo and in real time.
Typically, nanoparticles were injected into in vivo systems6,21, which is highly
invasive. Many of these studies used unpurified nanoparticles or functionalized
nanoparticles and did not consider effects of residual chemicals produced during
nanoparticle

synthesis

persisting

in

nanoparticle

solutions,

leading

to

inconclusive results.6
It is important to utilize this valuable in vivo model system and establish an
assay to look at the transport, biocompatibility and toxicity of NPs. Currently, the
biocompatibility of NPs, used as labeling agents for imaging cells and organisms,
are not well known. The primary challenges of establishing an in vivo assay for
screening the effects of NPs are (i) to accurately monitor the transport and the
death, deformity and normal phenotypes produced from exposure to the NPs, (ii)
to develop an in vivo assay that would share similarities to humans to establish
realistic biocompatibility and toxicity goals for human treatments and (iii) to
establish a standard in vivo assay that is efficient, easy to use, and affordable for
screening NPs.

In the following dissertation, we accomplished all of these

objectives, achieving a major advance in the in vivo screening of NPs.
In this dissertation, we developed new imaging and in vivo assay
approaches to characterize the transport, biocompatibility and toxicity of different
types of single silver (Ag) NPs, ranging from 12 to 95 nm.

We imaged at

nanometer resolution by measuring their size-dependent localized surface
plasmon resonance (LSPR) spectra and scattering intensity in living embryos
using dark-field optical microscopy and spectroscopy (DFOMS).

These new

approaches allowed us to characterize different types of single Ag NPs for
simultaneous imaging of multiple single NPs in living embryos. We also were
able to measure their sizes at nanometer resolution, with millisecond temporal
resolution, using optical microscopy in real-time. This study offers powerful new
tools to study multiple dynamic and molecular events of interest in vivo using
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multiple single NP optical probes and a valuable in vivo model assay via optical
microscopy.
This dissertation includes seven chapters. In Chapter I, we provide a brief
overview of the research background and significance of this dissertation
research, and outline the contents of each chapter.
In Chapter II, we describe the design of a standard in vivo assay that is
efficient, easy to use, and affordable to screen the transport, biocompatibility and
toxicity of 12 nm Ag NPs. These new approaches allowed us to create an in vivo
assay to screen single Ag NPs for biocompatibility while simultaneously imaging
and measuring sizes of multiple single NPs in real-time using DFOMS, as
illustrated in Figure 1. We were able to synthesize, characterize and purify Ag
NPs, 12 nm in size and incubated them with our living in vivo model system. We
determined that the Ag NPs (12 nm) were stable in the egg-water media and
were able to transport into the embryos via random diffusion causing various
deformities in a dose-dependent manner. This study offers powerful new tools to
study the dynamics of in vivo transport of NPs and the biocompatibility and
toxicity of NPs, as described in Chapter lll-VI.
In Chapter III, we utilize the Ag NP optical probes and imaging approaches
developed in Chapter II to probe the transport kinetics of Ag NPs used in Chapter
II in our in vivo model system at different stages of development in real-time at
nanometer resolution, as illustrated in Figure 2. We found that NPs transport into
the embryos in a stage-dependent manner causing stage specific related
deformity. This experiment demonstrates that plasmonic Ag NP probes can be
used to study the stage dependent effects during embryonic development in
single living embryos, offering the possibility of better understanding the
questions of development.
In Chapter IV, we used the zebrafish embryos as our in vivo model system
and imaging methods described in Chapter II to screen the transport, as well as

Deformity

Figure 1. Illustration of transport, biocompatibility and toxicity of single Ag
NPs in zebrafish embryos as an in vivo model system via DFOMS.

biocompatibility and toxicity of Ag NPs with different surface charges, as
illustrated in Figure 3. Unlike other NP biocompatibility experiments, we utilized
the purified single Ag NPs (12 nm) from Chapter II and conjugated them with
different peptides to create different surface charges to determine NPs surface
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Figure 2. Illustration of probing of stage-dependent transport,
biocompatibility and toxicity of single Ag NP probes using zebrafish
embryos.

Charge affects on developing zebrafish embryos in real-time. We determined
that these Ag-peptide NPs were also stable in the egg-water media prior to
incubation with the embryos.

Interestingly, we found that our in vivo model

system displayed charge-dependent biocompatibility and toxicity. This illustrates
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Figure 3. Illustration of using Ag-peptide NPs as optical probes with
varying surface charges for transport, biocompatibility and toxicity in living
zebrafish embryos in real-time.

the possibility of using different surface charged NPs, that are more
biocompatible, to probe the dynamics of embryonic development.
In Chapter V, we describe the synthesis and characterization of purified
larger Ag NPs (42.3 ± 6.3 nm) that are stable in egg-water medium. We studied
their biocompatibility and toxicity in vivo, as illustrated in Figure 4. Using imaging
approaches described in Chapter II, we observed the effects of larger Ag NPs on
the morphology, viability and transport of embryos at single NP and single live
embryo resolution. We found that the larger Ag NPs were more toxic, showing
dose-dependency, highly dependent upon the concentration of the nanoparticles,
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16.5%
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7.7%
Deformed

75.8%
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Figure 4. Illustration of using larger sized 42 nm single NP optical probes
for transport, biocompatibility and toxicity in living zebrafish embryos in
real-time.

demonstrating drastic changes in embryo morphology and an increase in the
amount of dead embryos.

This work demonstrates the possibility of using

smaller Ag NPs (12 nm) as a more biocompatible embryonic probe for potential
therapeutic drug carriers.
In Chapter VI, we synthesized and characterized larger (95 nm) single
molecule Ag NP optical probes, making sure that they were stable in egg-water
media.

We then used these single NP probes to map the transport and

biocompatibility and toxicity of large NPs on single living embryos in real-time, as
illustrated in Figure 5. We found that the larger NPs were more toxic and were

•

60.3% Normal

V \
10.6% D*form»d

29.1% Dead

Figure 5. Illustration of transport of 95 nm Ag NPs in single living embryos
and their biocompatibility and toxicity.

The results demonstrate that size does matter when related to NPs and that
smaller NPs are more suitable for quantitative imaging and probing of single
living embryos for any desired period of time. This offers new possibilities for
monitoring the dynamics of embryonic development in single living embryos in
real-time, emphasizing the importance of the study of

NP transport,

biocompatibility and toxicity on single living embryos.
In Chapter VII, we summarized our research findings described in the
preceding chapters, pointed out the primary contributions of these original
research activities, and emphasized the possible future research directions.
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CHAPTER II
REAL-TIME IMAGING OF TRANSPORT, BIOCOMPATIBILITY AND TOXICITY
OF SINGLE 12 NM SILVER NANOPARTICLES IN EARLY DEVELOPMENT OF
ZEBRAFISH EMBRYOS

INTRODUCTION
We select an effective in vivo model system (zebrafish embryos) and one
type of model nanomaterial (12 nm Ag nanoparticles) and focus on probing the
transport mechanism and dose-dependent biocompatibility of the nanomaterials
in vivo, targeting the initial entry step of nanomaterials into embryos. The aim is
to demonstrate the Ag NPs potential applications and address its potential
adverse effects.

Real-time study of transport and biocompatibility of single

nanoparticles in early development of embryos will provide new insights into
molecular transport mechanism and structure of developing embryos at
nanometer (nm) spatial resolution in vivo. As well as, assess the biocompatibility
of single nanoparticle probes in vivo.

RESULTS AND DISCUSSION
Synthesis and Characterization of Ag NPs
We synthesized spherical Ag NPs with average diameter of (11.6 ± 3.5)
nm by reducing AgCI04 with reducing agents (sodium citrate and sodium
borohydride) using well-tuned synthesis conditions as described in Methods. We
then carefully washed nanoparticles to remove trace chemicals from their
synthesis using centrifugation, generating highly purified nanoparticles.

We

characterized the stability, size and optical properties of these purified Ag
nanoparticles incubated in egg-water (1.2 mM NaCI) for 120 h using UV-vis
absorption spectroscopy, DFOMS, dynamic light scattering (DLS), and highresolution transmission electron microscopy (HR-TEM) (Fig. 6).
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Figure 6. Characterization of optical properties and stability of Ag
nanoparticles.
(A) Representative UV-vis absorption spectra of 0.71 nM Ag NPs for (i) 0 and (ii)
120 hours (B) Representative HR-TEM images Ag NPs. Scale bar = 5 nm. (C)
Representative dark-field optical image of single Ag NPs shows the majority are
blue.

(D) Representative LSPR spectra of single Ag NPs exhibit peak

wavelength at 452, 531, and 601 nm, respectively. (E) Histogram of size and
color distribution of nNPs to be 11.6 ± 3,5 nm, with 74% of 5-15 nm (blue), 23%
of 16-30 nm (green), and 1% of 31-46 nm (red) Ag nanoparticles.

(F)

Representative plots of scattering intensity of single NPs (i) and background (ii).
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The absorption spectra of freshly prepared and washed nanoparticles
before and after incubating with egg-water for 120 h (Figs. 6A: a & b) show an
absorbance of 0.736 at a peak wavelength of 396-400 nm, indicating that Ag
nanoparticles are very stable (not aggregated) in egg-water (1.2 mM NaCI). We
determined the effect of salt concentration (the positive control experiment) by
increasing NaCI concentration and found that nanoparticles are stable in the
presence of NaCI up to 10 mM, but begin to aggregate in 100 mM NaCI, showing
a red shift of peak absorbance wavelength (~2-3 nm) and a decrease in
absorbance. The size of nanoparticles measured by DLS increased from (10.1 ±
2.0) nm to (24.4 ± 2.7) nm in the presence of 100 mM NaCI. The presence of
sufficiently high concentration of NaCI (100 mM) appears to reduce the thickness
of electric double-layer on the surface of nanoparticles and decrease the zeta
potential below its critical point, leading to aggregation of nanoparticles.
We characterized the size of Ag NPs using HR-TEM and DLS before and
after incubating with egg-water for 120 h, showing that the size of nanoparticles
remained unchanged with an average diameter of 11.6 ± 3.5 nm. Furthermore,
we characterized the optical properties of individual nanoparticles using DFOMS
(Fig. 6: C-F). A representative optical image of single nanoparticles in Fig. 5C
illustrates that the majority of nanoparticles are blue with some being green and
few are red. The representative LSPR spectra of single blue, green and red
nanoparticles show peak wavelengths of 488, 532 and 607 nm (Fig. 6D),
respectively. The correlation of the color distribution of individual nanoparticles
with their size measured by HR-TEM, shows the majority (74%) of single
nanoparticles with diameters of 5-15 nm are blue, 23% of single nanoparticles
with diameters of 16-30 nm are green, and a very small fraction (1%) of
nanoparticles (31-46 nm) are red (Fig. 6E).

Thus, the color-index of single

nanoparticles can be used as a size-index to directly distinguish and determine
the size of nanoparticles (5-46 nm) using DFOMS, even though the size of
nanoparticles cannot be directly measured due to the optical diffraction limit. We
also found that the distribution of color and size of nanoparticles remained
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unchanged as nanoparticles were incubated in egg-water for 120 hr, suggesting
that nanoparticles are stable (not aggregated) in egg-water at single-nanoparticle
resolution.
To determine the photostability of Ag nanoparticles, we acquired
sequence images of single Ag nanoparticles while these nanoparticles were
constantly radiated under a dark-field microscope illuminator (100 W halogen) for
12 hr. The illumination power at the sample stage (focal plane of dark field) was
0.070 ± 0.001 Watt.

Representative plots of scattering intensity of single

nanoparticles and background (in the absence of nanoparticles) versus
illumination time in Fig. 6F indicate that the scattering intensity of individual single
nanoparticles remains unchanged over 12 h, showing that single Ag
nanoparticles resist photodecomposition and blinking.

Note that the small

fluctuations of intensity of single nanoparticles (Fig. 6F: i) are similar to those
observed from the background (Fig. 6F: ii), suggesting that the intensity
fluctuations are attributable to the illuminator and the noise level of the CCD
camera.

Probing Diffusion and Transport of Single Nanoparticles in Cleavage Stage
Embryos
Representative developmental stages of the zebrafish embryos in 120
hour-post-fertilization (hpf) in Fig. 7 show the cleavage stage (8-64 cell stages),
segmentation stage, hatching stage, and pharyngula stage embryos, and a fully
developed zebrafish in the absence of nanoparticles. At the cleavage-stage (864 cell stage; 0.75-2.25 hpf) (Fig. 7A-B), embryos undergo dramatic changes
(e.g., rapid cellular division and distinct fate establishment) to lay down the
foundation for developing the different parts of organs and a variety of interesting
but not yet well-understood biochemical and biophysical events (e.g., cell
migration signaling and embryonic pattern formation) occur. This stage is crucial
in development as the foundation and organization of the embryos are being
assembled.22,23 Thus, it is important to understand the diffusion and transport
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Figure 7. Optical images of the representative developmental stages of
normally

developed

zebrafish

in

egg-water

(in

the

absence

of

nanoparticles) and representative anatomical structures.
(A) 1.25-1.50 hpf (8-cell stage); (B) 2-2.25 hpf (64-cell stage); (C) 24 hpf
(segmentation stage); (D) 48 hpf (hatching stage); (E) 72 hpf (pharyngula stage);
(F) a completely developed zebrafish at 120 hpf and (G) representative
anatomical structures of the zebrafish: (i) finfold, (ii) tail region, (iii) yolk sac, (iv)
heart, and (v) eye. Scale bar = 500 pm. hpf = hour post fertilization.

mechanisms among the various parts of embryos at this particular stage. The
cleavage stage embryos may also be most sensitive to foreign substances24,
offering an ultrasensitive in-vivo model system to study the biocompatibility and
subtle effects of nanoparticles on the embryonic development.
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To study diffusion and transport of single nanoparticles into cleavage
stage embryos, we incubated Ag nanoparticles with the embryos and directly
observed and characterized their transport.

We found that Ag nanoparticles

(blue, green and red) transport into the chorionic space (cs) via chorion pore
canals (CPCs) and enter into the inner mass of embryo (ime) (Fig. 8). We used
our optical imaging system to directly measure the diameters of chorion pore
canals, showing them to be approximately 0.5-0.7 pm in diameter with distances
between the centers of two nearby chorion pore canals are at -1.5-2.5 pm, which
agrees well with those reported using TEM.25 To our knowledge, this study
demonstrates for the first time direct observation of chorionic pore canals of
single living embryos using optical microscopy.

We show that the sizes of

chorion pore canals are much larger than the size of nanoparticles, permitting the
passive diffusion of individual nanoparticles into the chorionic space of embryos.
To determine the transport mechanism of Ag nanoparticles, we utilized the
concept of 2D mean-square-displacement (MSD) and diffusion models (e.g.,
directed, simple and stationary Brownian diffusion)26,

27

to investigate each

diffusion trajectory of single nanoparticles in egg-water, entry into embryos, and
inside embryos. To follow the diffusion of single nanoparticles inside various
parts of embryos in real-time, we used real-time square-displacement (RTSD)
(diffusion distance at a given time interval), instead of average (mean) of squaredisplacement over time, because the diffusion coefficient could vary as single
nanoparticles diffuse in embryos.

This approach allowed us to probe the

diffusion of single nanoparticles and viscosity of the different parts of embryonic
fluids (e.g., chorionic space, inner mass of embryo) in real-time. The diffusion
coefficient (D) of single nanoparticles in simple Brownian motion is calculated by
dividing the slope of a linear plot of real-time square-displacement versus time by
4 (Note: RTSD = 4DAt).
Representative diffusion trajectories of single Ag nanoparticles trapped
inside chorion pore canals, in chorionic space and near the inner mass of
embryo, and analysis of these diffusion trajectories using the real-time square-
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Figure 8. Real-time monitoring and characterization of transport of
individual Ag nanoparticles in a cleavage-stage living embryo .
(A) Optical image of a cleavage-stage embryo shows chorionic space (CS), yolk
sac (YS), and inner mass of embryo (IME).

(B) Sequence dark-field optical

images illustrate the transport of single Ag nanoparticles, as indicated by the
circle, from the egg-water (extra embryo) into the chorionic space via an array of
chorion pore canals (CPCs) highlighted by a rectangle. (C) Sequence dark-field
optical images illustrate the transport of single Ag NPs, as indicated by the circle,
from chorionic space into inner mass of embryo.

The straight and curved

dashed-lines illustrate the interface of inner mass of embryo with chorionic
space, and chorionic space with egg-water, respectively. The time interval of
each sequence image in both (B) and (C) is 25 s. Scale bar = 400 pm in (A) and
15 pm in (B-C).
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displacement method are shown in Fig. 9. The results illustrate that single Ag
nanoparticles inside the chorionic space (either near the chorion layers or inner
mass of the embryo) exhibit simple Brownian diffusion (not active transport) with
~26 times slower diffusion rate (3x10"9 cm2/s) than those in egg-water (7.7x10"®
cm2/s), showing that single Ag nanoparticles diffuse into the chorionic space via
passive diffusion and that the viscosity of chorionic space is about 26 times
higher than that of egg-water.
As nanoparticles make several attempts to enter the chorion layers and
inner mass of the embryo, their diffusion patterns are restricted (Fig. 9B: a-i,
steps in a-ii and a-iii), suggesting that the nanoparticles dock into the chorion
pore canals, which halts their normal diffusion. By tracking the entry of individual
nanoparticles into chorion pore canals, we measured the period of time that
individual nanoparticles stay in the pores, which ranges from 0.1 to 15 s.
We characterized the diffusion coefficient of blue, green and red
nanoparticles in egg-water (Fig. 9B: b) to determine the possible variation of
diffusion coefficients due to the different sizes (radii) of single nanoparticles,
showing simple Brownian diffusion with D of 8.4 x10~8, 6.0 x10~8 and 5.5 x10"8
cm2/s, respectively. The diffusion coefficients are inversely proportional to their
radius, as described by the Stoke-Einstein equation, D = kT/(6rcria), showing that
the diffusion coefficient (D) depends on the viscosity of medium (ri) and the
radius (a) of solute (nanoparticle).28,29

The diffusion coefficients of the given

color (radius) of nanoparticles in embryos were studied and compared with those
in egg-water, showing that the various diffusion coefficients observed in three
different parts of embryos (Fig. 9B: a) were indeed attributable to the viscosity
gradient inside embryos, but not the different radii of individual nanoparticles.
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Figure 9. Characterization of transport and diffusion of single Ag NPs in a
cleavage (64-cell) stage living embryo.
(A) Diffusion trajectories of single Ag nanoparticles: (i) a red nanoparticle inside
the chorion layers, (ii) a blue nanoparticle inside chorionic space, and (iii) a green
nanoparticle at the interface of inner mass of embryo and chorionic space. (B)
Plots of real-time square-displacement (RTSD) as a function of time: (a) single
nanoparticles from the diffusion trajectories shown in A (i-iii) illustrate that (i) a
red nanoparticle in a restricted and stationary diffusion mode with a diffusion
coefficient (D) < 1.9x10"11 cm2/s, due to entrapment inside chorion pore canals;
(ii) a blue nanoparticle in chorionic space away from the inner mass of embryo;
and (iii) a green nanoparticle inside chorionic space near the surface of inner
mass of embryo, both in a simple Brownian motion with D of 3.4x10"9 cm2/s and
2.6x1CT9 cm2/s, respectively; (b) a representative single (i) blue, (ii) green and (iii)
red nanoparticle in egg-water. All show simple Brownian diffusion with D of 8.4
x10"8, 6.0 x10"8 and 5.5 x10"8 cm2/s, respectively.
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Imaging and Characterization of Transport and Embedded Nanoparticies
Images of single nanoparticies diffusing into the chorionic space were
recorded using DFOMS equipped with a color camera, instead of CCD, showing
that nanoparticies of multiple colors transport into the chorionic space (Fig. 10A).
Note that single Ag nanoparticies exhibit colors (LSPR), which depends on its
size, shape and surrounding environments.30"33 This feature allowed us to
distinguish single Ag nanoparticies from any possible tissue debris or vesicle-like
particles in embryos, which do not exhibit surface plasmon and hence appear
white under dark-field microscope (Figs. 8 & 9). We found that the majority of
NPs transported into the chorionic space and some of them overlapped with
chorion pore canals (Fig. 10A: a). The representative LSPR spectra (colors) of
individual nanoparticies inside chorionic space (Fig. 10A: b) show similar peak
wavelengths as those observed in egg-water in Fig. 6D. The results indicate that
the majority of nanoparticies remained non-aggregated inside embryos.
Otherwise, we would have observed a significant red shift of LSPR spectra of
individual nanoparticies.
Although the majority of single nanoparticies can freely diffuse into
embryos and remain non-aggregated, some single nanoparticies stay in chorion
pore canals for an extended period of time. These trapped nanoparticies serve
as nucleation sites and aggregate with incoming nanoparticies to form larger
particles (dark-red nanoparticies) (Fig. 10B), clogging chorion pore canals and
affecting the embryo's transport. Note that, embryos at this developmental stage
are free of pigmentation.
As the cleavage (8-cell) stage embryos chronically treated with lower
concentrations of Ag nanoparticies (< 0.08 nM) completed their embryonic
development at 120 hpf, we characterized Ag nanoparticies embedded in fully
developed zebrafish using DFOMS and found that these Ag nanoparticies
embedded in multiple organs (retina, brain, heart, gill arches, and tail) of normally
developed zebrafish (Fig. 11), demonstrating that Ag nanoparticies are
biocompatible to embryos at lower concentrations (< 0.08 nM).

The LSPR

spectra of these embedded nanoparticies are similar to those observed in Figure
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Characterization of Ag nanoparticles embedded in embryos

using dark-field DFOMS.
(A) Representative (a) color image and (b) LSPR spectra of single Ag
nanoparticles embedded in chorion layers show that single Ag nanoparticles with
multiple-colors (blue, green, red) are present inside chorion layers, and some
nanoparticles are overlapped with the chorion pore canals (note that an array of
chorion pore canals are highlighted by a triangle).

Scale bar = 1 nm.

(B)

Representative images of individual Ag nanoparticles embedded in the chorion
layers illustrate those Ag nanoparticles (as indicated by a circle) trapped in the
chorion pore canals outlined by ellipses. The CCD image in (a) is enlarged and
shown in (b). The zoom-in color image of (b) is shown in (c), indicating that the
dark-red nanoparticles clog the chorion pore canals. Scale bar = 10 ^im in (a); 2
jim in (b). OC = outside chorion
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Figure 11.

Characterization of individual Ag nanoparticles embedded

inside a fully developed (120 hpf) zebrafish using DFOMS:
(A) Optical image of a fixed normally developed zebrafish. The rectangles (i-v)
highlight representative areas: (i) retina, (ii) brain (mesencephalon cavity), (iii)
heart, (iv) gill arches, and (v) tail.

(B) Zoom-in optical images of single Ag

nanoparticles embedded in those tissue sections outlined in (A). Dashed circles
outline the representative embedded individual Ag nanoparticles. Scale bar =
400 pm in (a); 4 pm in (b).

9A:b.

We also performed blank control experiments by imaging 120-hpf

zebrafish that developed in the absence of nanoparticles and did not observe the
signature LSPR spectra (color) of Ag nanoparticles in these fully developed
zebrafish.

Dose-dependent biocompatibility and toxicity
To determine the effect of dose of Ag nanoparticles on embryonic
development, we treated the cleavage stage (8-cell stage) embryos chronically
with various concentrations of Ag nanoparticles (0 - 0.71 nM) and carefully
monitored and characterized their vital developmental stages (24, 48, 72, 96, and
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120 hpf).

The results in Fig. 12 A & B show that biocompatibility of Ag

nanoparticles and the types of abnormalities in treated zebrafish are highly
dependent on the dose of Ag NPs. In the presence of lower concentrations (<
0.08 nM) of nanoparticles, a higher percentage of normally developed zebrafish
is observed than that of dead and deformed zebrafish. Note that both normal
and deformed zebrafish developed from the cleavage (8-cell) stage embryos that
had been simultaneously incubated with the same nanoparticle solution. Thus,
the results suggest that some embryos might be more tolerant to the
nanoparticles than others. The results also suggest that Ag nanoparticles might
affect the development of embryos stochastically due to the random diffusion of
nanoparticles.
As nanoparticle concentration increases, the number of normally
developed zebrafish decreases, while the number of dead or deformed zebrafish
increases (Fig. 12: a). As nanoparticle concentration increases beyond 0.19 nM,
only dead and deformed zebrafish are observed, showing a critical concentration
of Ag nanoparticles on the development of zebrafish embryos (Fig. 12). The
blank (negative) control experiments, conducted by replacing nanoparticles with
the supernatant resulting from washing Ag nanoparticles, show that the survival
rate of zebrafish is independent of the dose of supernatant (Fig. 12: b),
demonstrating that residual chemicals from nanoparticle synthesis are not
responsible for the deformation and death of zebrafish, but rather the
nanoparticles that were used to treat the zebrafish embryos (Fig. 12: a).
The number of deformed zebrafish increased to its maximum as
nanoparticle concentration increased to 0.19 nM, and then decreased as
nanoparticle concentration increased from 0.19 to 0.71 nM (Fig. 12: c) because
the number of dead zebrafish increased.

Interestingly, the types of viable

deformities exhibit high dependence on the nanoparticle concentration (Fig. 12:
d).

For example, the finfold abnormality and tail/spinal cord flexure and

truncation were observed in zebrafish treated with all tested nanoparticle
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Biocompatibility and toxicity of nanoparticles show high

dependence on nanoparticle concentration.
Histogram of distribution of normally developed (•) and dead (•) zebrafish, (a)
versus concentration of Ag nanoparticles; (b) versus concentration of
supernatants resulting from washing Ag nanoparticles (negative control);

(c)

histogram of distribution of deformed zebrafish (120 hpf) (•) versus concentration
of Ag nanoparticles; (d) histogram of distribution of five representative types of
deformities of the zebrafish versus concentration of Ag nanoparticles: finfold
abnormality (•), tail and spinal cord flexure and truncation (•), cardiac
malformation (•), yolk sac edema (•), head edema (•), and eye abnormality (•).
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concentrations (0.04-0.71 nM) with the highest occurrences at 0.19 and 0.38 nM,
respectively.

Cardiac malformation and yolk sac edema were observed in

zebrafish treated with the slightly higher nanoparticle concentrations (0.07-0.71
nM) with the highest occurrences at 0.66 nM. In contrast, head edema and eye
deformity were only observed in the higher concentrations of nanoparticles, 0.440.71 and 0.66-0.71 nM, respectively. Among all types of observed deformities,
finfold abnormality occurred at the highest rate, followed by tail and spinal cord
flexure and truncation, then cardiac malformation and yolk sac edema, and finally
head edema and eye abnormality, which were rarely observed deformations of
zebrafish and quickly led to zebrafish death.
Representative deformed zebrafish induced by nanoparticles are
illustrated in Fig. 13:b-g. In comparison with the normally developed zebrafish in
Fig. 13-a, we found characteristics of finfold abnormality (Fig. 13-b), tail and
spinal cord flexure and truncation (Fig. 13-c), cardiac malformation (Fig. 13-d),
yolk sac edema (Fig. 13-e), head edema (Fig. 13-f), and eye abnormality (Fig.
13-g) of zebrafish that developed from the 8-cell embryos treated chronically by
Ag nanoparticles. Interestingly, multiple deformities occurred in one zebrafish at
the higher nanoparticle concentrations (> 0.38 nM). For example, in yolk sac
edema zebrafish, we also observed tail/spinal cord flexure, finfold abnormality,
and cardiac malformation (Fig. 13: c-iv & e-ii), head edema (Fig 13: e-ii, e-iv and
f-ii), and eye abnormality (Fig 13: g-i).

These findings suggest that specific

embryonic developmental pathways might be co-regulated, and that some
deformities (e.g., finfold, tail, spinal cord) are much more sensitive to the
nanoparticles than others (e.g., head edema, eye abnormality).
To determine the possible targets for further genomic and proteomic
studies and evaluate the toxicity of Ag nanoparticles against well-studied toxic
chemicals,

such

as

cadmium,

dichloroacetic

acid

(DCA),

2,3,7,8-

tetrachlorodibenzo-p-dioxin (TCDD), and ethanol, we compare the characteristics
of deformation of zebrafish induced by Ag nanoparticles with those generated by
well-known toxic chemicals. We found that the observed finfold abnormality and
tail/spinal cord flexure and truncation induced by Ag nanoparticles (Fig. 13: b & c)
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Biocompatibility and toxicity of nanoparticles show high

dependence on nanoparticle concentration.
Representative optical images of (a) normally developed and (b-g) deformed
zebrafish: (a) the normal development of (i) finfold, (ii) tail/spinal cord, (iii)
cardiac, (iii-iv) yolk sac, cardiac, head and eye; and (b-g) deformed zebrafish: (b)
finfold abnormality; (c) tail and spinal cord flexure and truncation; (d) cardiac
malformation; (e) yolk sac edema; (f) head edema: (i) head edema; (ii) head
edema and eye abnormality; (g) eye abnormality: (i) eye abnormality; (ii) eyeless.
Scale bar = 500 (jm.
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are similar to those treated by DCA and cadmium34,

35,

common targets of malformation during development.

The observed cardiac

indicating possible

malformation and yolk sac edema in this study (Fig. 13: d & e) are also similar to
those treated with DCA and cadmium.34,35 The shrunken ventricular myocardium
observed in cardiac malformed zebrafish induced by nanoparticles (Fig. 13: d) is
similar to those treated with TCDD.36 Head edema and eye abnormality in Fig.
13B: f & g-i have also been found in treatment of zebrafish with cadmium.34
Although the eye malformation (a cycloptic eye development) had been
observed in zebrafish treated by ethanol,37 the deformation is unlike what we
have observed (eyeless, no formation of retina or lens) in Fig. 13B: g-ii. Thus,
the eyeless deformation (Fig. 13B: g-ii), an undeveloped set of optic cups with no
retina or eye lens, to our knowledge, is a new occurrence of malformation that
has not been reported previously.

This abnormality may be related to the

nanoparticles disrupting the regulators or signaling cascades involved with the
normal development of the neural retinal layers and the lens of the zebrafish's
eye. Pax-6, a transcription factor, has been studied and shown to affect the
development of the eye retinal layers.
develop.37,

38

In Pax-6 mutants, the lens fails to

However, another transcription factor, Six-6, regulating neural

retinal development in zebrafish has not been studied in detail and it may also
play the role in eye deformation as well.38

Further studies are needed to

determine whether Ag nanoparticles inhibit or regulate the expression of
transcription factors (e.g., Pax-6 and Six-6), leading to the eyeless deformation.
Plausible

explanations

for

the

high

dependence

of

embryonic

abnormalities on the dose of nanoparticles include the following: (i) The rate of
passive diffusion (permeability) and accumulation of nanoparticles in chorion
pore canals and embryos highly depends on the concentration gradient of
nanoparticles. Thus, the dose of nanoparticles plays a vital role in determining
the rate and amount of nanoparticles that can penetrate into particular
compartments of embryos, and the rate and number of chorion pore canals
blocked by the aggregation of nanoparticles (Figs. 9-11). (ii) The accumulated
nanoparticles inside embryos can also alter the charge, diffusion, and
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interactions of biomolecules (e.g., nucleic acids, proteins such as transcription
factors, signaling molecules) in a dose-dependent manner, leading to
interference or malfunctioning of signaling cascades.
Taken together, these results suggest that specific pathways of embryonic
development respond to Ag nanoparticles in a dose dependent manner, and
demonstrate that the nanoparticles may elicit unique response from embryonic
neural development pathways. The study demonstrates the possibility of finetuning the dose of nanoparticles to (i) selectively target specific pathways to
create particular phenotypes, (ii) selectively generate specific mutations in
zebrafish, and (iii) serve as potential therapeutic agents to treat specific disorders
in embryonic development. Unlike other chemicals, single nanoparticles can be
traced and imaged inside developing embryos and developed zebrafish with
nanometer spatial resolution in real-time, offering new opportunities to unravel
the related pathways that lead to the abnormalities.

Work is in progress to

identify the related specific pathways and signaling cascades at the genomic and
proteomic levels and to further explore potential therapeutic effects of
nanoparticles.
SUMMARY
In summary, we have designed, synthesized and characterized single
nanoparticle optical probes (individual Ag nanoparticles) for probing their
transport, biocompatibility and toxicity in early development of zebrafish embryos
in real-time.

We

have

shown

that

single

Ag nanoparticles

resist

photodecomposition and blinking and can be directly monitored in embryos for an
extended period of time. Furthermore, individual Ag nanoparticles exhibit sizedependent LSPR spectrum (color), which permits us (i) to distinguish them from
tissue debris and vesicles in embryos, (ii) to directly image and characterize the
sizes of individual nanoparticles in solution and in living embryos in real time, (iii)
to probe their diffusion, transport mechanism and biocompatibility in living
embryos in real time, and (iv) to investigate the embryonic fluids (e.g., viscosity)
at nm spatial resolution in real time. We found that individual Ag nanoparticles
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can passively diffuse into developing embryos via chorion pore canals, create
specific effects on embryonic development and selectively generate particular
phenotypes in a dose-dependent manner.

The early embryos are highly

sensitive to the nanoparticles, showing the possibility of using zebrafish embryos
as an in vivo assay to screen the biocompatibility and toxicity of nanomaterials.
This study represents the first direct observation of passive diffusion of
nanoparticles into an in vivo system (an important aquatic species), suggesting
that the release of large amounts of Ag nanoparticles into aquatic ecosystems
(e.g., rivers) may have drastic environmental consequences, should the sizes of
nanomaterials remain unchanged during environmental transport.

This study

also represents the first most rigorous study and characterization of nano-toxicity
and nano-biocompatibility ever performed by investigating the effect of highly
purified nanoparticles in vivo in real time and considering the effect of possible
trace chemicals from nanoparticle synthesis.

METHODS
Reagents and Supplies
Sodium citrate (99%), AgCI04 (99%), NaBH4 (98%), and NaCI were
purchased from Sigma-aldrich.

All reagents were used as received.

The

nanopure water (18 MQ water, Barnstead) was used to prepare all solutions and
rinse glassware.

Synthesis and Characterization of Ag NPs
Silver nanoparticles were synthesized by reducing a 0.1 mM silver
perchlorate solution with a freshly prepared ice-cold solution of 3 mM sodium
citrate and 10 mM sodium borohydride under stirring overnight, and filtered
through a 0.22 pm filter.39,

40

The nanoparticles were washed twice with

nanopure water using centrifugation to remove the chemicals involved in
nanoparticle synthesis, and the nanoparticle pellets were resuspended in
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nanopure water before incubating with embryos. The washed Ag nanoparticles
are very stable (non-aggregated) in nanopure water for months and remain
stable in egg-water throughout the entire experiments (120 hpf).

The

supernatants of nanoparticle solutions after the second washing were collected
for control experiments to study the effect of trace chemicals involved in
nanoparticle synthesis on the development of embryos.

The concentration,

optical properties, and size of nanoparticles were characterized using UV-vis
spectroscopy, dark-field optical microscopy and spectroscopy (DFOMS)40"42,
high-resolution transmission electron microscopy (HR-TEM) (FEI Tecnai G2 F30
FEG), and dynamic light scattering (DLS) (Nicomp 380ZLS particle sizing
system), respectively. Our DFOMS has been well described previously for real
time imaging and spectroscopic characterization of single nanoparticles in single
living cells and for single molecule detection.29,4CM4 The detector, EMCCD or LN
back-illuminated CCD camera coupled with a SpectraPro-150 (Roper Scientific),
was used in this study. All chemicals were purchased from Sigma and used
without further purification or treatment.
To determine the photostability of single Ag nanoparticles, we acquired
sequence images of single Ag nanoparticles using EMCCD camera with
exposure time at 100 ms and readout time of 40.6 ms while these nanoparticles
were constantly radiated under dark-field microscope illuminator (100 W halogen)
for 12 hr. The illumination power at the sample stage (focal plane of dark field) is
0.070 ± 0.001 Watt. The integrated scattering intensity of single nanoparticles
and background (in the absence of nanoparticles) within a 20x20 CCD pixel area
was measured. The integrated scattering intensity of background is subtracted
from that of same size of detection area in the presence of individual
nanoparticles to calculate the scattering intensity of single nanoparticles. The
experiments were repeated at least three times.

The average subtracted

integrated intensity of the single nanoparticles and background was plotted as a
function of time. The fluctuations of intensity of single nanoparticles were used to
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compare

with

those

of

background

to

determine

the

photostability

(photodecomposition and blinking) of single nanoparticles.

Breeding and Monitoring of Zebrafish Embryos
Wildtype adult zebrafish (Aquatic Ecosystems) were maintained, bred, and
collected, as described previously.45 Embryos were collected and transferred
into a petri dish containing egg-water (1.2 mM stock salts in Dl water), washed
twice with egg-water to remove the surrounding debris, and placed into 24-well
plates with each well containing two embryos in egg-water. Each developmental
stage of embryos in the wells was directly imaged by bright-field optical
microscopy using an inverted microscope equipped with a 4x objective and a
digital camera.
In vivo Characterization and Analysis of Transport and Dose-dependent
Biocompatibility and Toxicity of Nanoparticles
Cleavage-stage living embryos (8-64 cell stage; 0.75-2.25 hpf) that had
been incubated with 0.19 nM nanoparticles for a given time (0-2 hours) were
either immediately imaged to investigate the transport of nanoparticles into
embryos or carefully rinsed with Dl water to remove external nanoparticles, and
placed in a self-made microwell containing Dl water to image the diffusion and
transport of nanoparticles inside the embryos in real-time using our DFOMS.
To study the dose-dependent effects of nanoparticles on embryonic
development, a dilution series of washed Ag nanoparticle solutions (0, 0.04, 0.06,
0.07, 0.08, 0.19, 0.38, 0.57, 0.66, and 0.71 nM) were incubated chronically with
cleavage (8-celi) stage embryos in egg-water for 120 hpf. Each experiment was
carried out at least three times and total number of embryos at 35-40 was studied
for each individual concentration to gain representative statistics. Nanoparticle
concentrations were calculated as described previously.46 Embryos in egg-water
in the absence of nanoparticles and in the presence of supernatant were placed
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in two rows of the 24-well plates as control experiments of untreated embryos
and probing the effect of possible trace chemicals from nanoparticle synthesis,
respectively. The embryos in the 24-well plates were incubated at 28.5°C, and
directly observed at room temperature using an inverted microscope equipped
with a digital camera at 24, 48, 72, 96, and 120 hpf.

Characterization of Nanoparticles Embedded Inside Embryos and Fully
Developed Zebrafish
To characterize the embedded nanoparticles in the tissues of treated
zebrafish, we selected living developed zebrafish that had been chronically
incubated with a given concentration (0.04 nM) of nanoparticles for 120 hpf since
their cleavage (8-cell) stage, and carefully rinsed the zebrafish with Dl water to
remove external nanoparticles. The fixed zebrafish were prepared using 10%
buffered formalin via a standard histology protocol of tissue sample preparation.47
The thin-layer microsections (~5 pm thickness) were prepared by carefully
dissecting tissues of interest (e.g., eye retina, brain, heart, gill arch, tail and
spinal cord) under microscopy using microtome. The embedded nanoparticles in
the tissues were directly characterized using DFOMS (Fig. 11).
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CHAPTER III
STUDY OF STAGE DEPENDENT TRANSPORT, BIOCOMPATIBILITY AND
TOXICITY OF SINGLE 12 NM SILVER NANOPARTICLES USING EARLY
DEVELOPMENT OF ZEBRAFISH EMBRYOS

INTRODUCTION
Nanoparticles (NPs), with their small size and unique physical properties,
are ideal for use in probing the nano-environments of living organisms enabling
the study of the changing environment of a developing living organism at specific
developmental stages of embryonic development.3,9i

48"50

NP probes can be

used in a variety of applications for new insight into developmental processes,
such as development screening tools in developmental biology to investigate the
embryonic internal environment, to potentially control and regulate certain
processes in development, and to target specific system regulators for
biomedical biological uses.

Nanomaterials could possibly demonstrate

developmental stage dependent regulation of deformity type induced, suggesting
that the nanomaterials, at higher concentration, may interact with target
developmental pathways of interest.
described

nanomaterials,11

In this study, we used our previously

Ag NPs, and an effective embryo developmental

model system, zebrafish embryos, and focused on acute developmental stagedependent diffusion and biocompatibility targeting important developmental
stages for analysis and independent NP entry into each embryonic stage, hoping
to identify possible developmental stage applications and the ability for NPs to
enter the developing embryo independent of the time of development.
The zebrafish has been used as a model organism for many chemicalscreening and drug studies; however the acute biocompatibility on different
zebrafish developmental stages is limited.51,52 The acute biocompatibility of Ag
NPs on specific sensitive stages of embryonic development has, to our
knowledge, never been attempted. It is important to explore the transport and
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biocompatibility of Ag NPs acutely at specific stages of embryonic development
to access the ability of Ag NPs to be used for in vivo imaging at any embryonic
stage of development as well as probes in real-time to explore the changing
embryonic environment during development.
The main challenges of using NP probes for specific developmental
stages for in vivo imaging and probing the environmental changes of the
developing embryo are (i) to ensure that the NPs transport into the embryo
environment regardless of the stage of development into the physiological
medium without any aid, such as microinjection (ii) to be able to track the
transport, diffusion and characterization of individual NPs in vivo at different
embryonic stages of development to study the differences in the embryonic fluid
environment, and (iii) to be able to study the biocompatibility of the NPs at
specific stages of embryonic development to assist in determining the NP
interactions.

In this study, we have accomplished all of these objectives,

achieving a major advance in the study of single NPs in vivo.
RESULTS AND DISCUSSION
Synthesis and Characterization of Ag nanoparticles (NPs)
We

used

our

previously

developed

sphere-shaped

silver-based

nanoparticles that were washed to remove any chemicals that remained from the
synthesis to study their interactions and biocompatibility with key stages in
developmental biology to determine Ag NPs role in developmental processes,
including stage

dependent

morphological

responses and

concentration

dependent morphological responses, for the potential of use as developmental
intermediates for biomedical applications.11 We characterized the stability, size
and optical properties of the purified Ag NPs in egg-water embryo media (1.2 mM
NaCI) for 120 hrs using UV-vis absorption spectroscopy, dark field optical
microscopy and spectroscopy (DFOMS) and high resolution transmission
electron microscopy (HRTEM).
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We characterized the size of the Ag NPs using HRTEM and the size was with an
average diameter of 13.1 ± 2.5 nm (Fig. 14A and B). A representative optical
image of Ag NPs in Fig. 14C illustrates that majority of NPs appear to be blue
with some green and a few red. These results suggest that Ag NPs are uniform
in size and shape based on their color (LSPR).

The representative LSPR

spectra of single blue, green and red Ag NPs with peak wavelengths (Amax) at
468 nm (blue) (FWHM = 38 nm), 554 nm (green) (FWHM = 47 nm), and 659 nm
(red) (FWHM = 47) nm, respectively (Fig. 14D). Thus color of Ag NPs can be
used as size index to directly distinguish and determine the size of NPs using
DFOMS, even though size of NPs cannot be directly measured due to the optical
diffraction limit. The number of NPs per image, using 20 images, at to, t0 +12h, to
+24h, to +48h, to +72h, to + 96h and to +120h were determined to be 65 ± 0, 66 ±
2, 67 ± 3, 67 ± 4, 70 ± 5, 67± 3 and 67± 4 (Fig. 14E). We found that the number
of NPs remained relatively unchanged when incubated in egg-water for 120 hrs.
The absorbance spectra of freshly prepared and purified Ag NPs before and after
the incubation time with egg-water demonstrated a peak wavelength (Amax) at 392
nm (FWHM = 64 nm) and remained unchanged for 120hrs (Fig. 14F).

The

unchanged number of NPs and stable absorbance spectra indicates that the Ag
NPs are very stable in egg-water media and remain non-aggregated.
Characterization of transport of nanoparticles (NPs) in different stage
embryos
The normal course of embryonic development in zebrafish in the absence
of NPs for each acute treatment stage is depicted in Fig 15. Acute treatment
occurred at five different stages of development for a 2 h incubation time with
NPs: stage I, cleavage stage (2-4 hpf) (Fig. 15A (a)), stage II, gastrula stage (6- 8
hpf) (Fig. 15A (b)), stage III, early segmentation stage (12 -14 hpf) (Fig. 15A (c)),
stage IV, late segmentation stage (21- 23 hpf) (Fig. 15A (d)) and stage V, during
the hatching period (48 - 50 hpf) (Fig. 15A (e)). The stages were determined by
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Figure 14. Characterization of optical properties and stability of Ag NPs
(A) Representative HRTEM image demonstrates the size and spherical shape of
single Ag NPs. Scale bar = 10 nm. (B) Histogram of size distribution of Ag NPs
measured by HRTEM shows the average size to be 13.1 ± 2.5 nm.

(C)

Representative dark-field optical image of single Ag NPs shows that majority of
NPs are blue with some green and red. Scale bar = 2 pm. (D) LSPR spectra of
single Ag NPs with multiple colors (blue, green, and red), with peak wavelengths
(Amax) at (a) 468 nm (blue) (FWHM = 38 nm), (b) 554 nm (green) (FWHM = 47
nm), and (c) 659 nm (red) (FWHM = 47 nm). (E) The # of NPs/ image (20
images) at to,

to

+12h, to +24h, to +48h, to +72h, to + 96h and to +120h were , 65 ±

0, 66 ± 2, 67 ± 3, 67 ± 4, 70 ± 5, 67± 3 and 67± 4. (F) Representative UV-Vis
absorption spectra of 0.70 nM Ag NPs well-dispersed in egg-water at 28°C for (a)
0 and (b) 120 h shows the peak absorbance at 0.491 and peak wavelength at
392 nm (FWHM = 64 nm) and remains unchanged for 120 h.

choosing critical events in embryonic development for study with NP transport
and biocompatibility. During stage I, embryos undergo dramatic changes, such
as rapid cellular division and embryonic pattern formation.22,23 During stage II,
embryos undergo cell movements and migration and establishment of the early
organ systems.53' 54 In stage III, embryos begin somitogenesis and notochord
formation, which is important for proper development of the axial skeleton, the
vertebrate spinal column, and the skeletal muscle.53,55 During stage IV, embryos
undergo development of the circulatory system and the heart is being formed.53
During stage V, the embryo is in the hatching stage and finishing its
development.

It is important to understand the diffusion and transport

mechanisms among the various embryonic stages to investigate the differences
in the embryonic environment and determine which developmental process may
be most sensitive to the NPs.
Embryos at each stage were observed throughout development after acute
treatment with NPs. Stage I - IV embryos were observed after acute treatment at
24 hours post fertilization (hpf) (Fig. 15B (a)), 48 hpf, (Fig. 15B (b)), 72 hpf, (Fig
15B (c)), 96 hpf, (Fig. 15B (d)), and 120 hpf, (Fig. 15B (e)). Stage V embryos
were observed after acute treatment at 72 hpf through 120 hpf, (Fig. 15B (c-e)).

Probing transport and diffusion of single Ag NPs in different stage
embryos
To study the transport and diffusion of single Ag NPs into different stage
embryos, we incubated 0.2 nM Ag NPs at the specific embryonic developmental
stages as demonstrated in Figure 16 A-E and directly observed and
characterized their transport at important areas of transport into the embryo
through the chorion layers (CL) (Fig. 16A-E (a)) into the chorionic space (CS)
(Fig. 16A-D (b)) via the chorion pores and into the inner mass of the embryo
(IME) (Fig. 16A-D (c)). We were not able to characterize transport of the Ag NPs
in the CS and IME of stage V due to the movement of the zebrafish larvae. We
used our state of the art optical imaging system to directly measure the transport
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Figure 15. Normally developed zebrafish at stages I - V at the time of acute
treatment and observations after acute treatment.
(A) Representative optical images of normally developed zebrafish at the time of
acute treatment for stage I - V, (a) 2 hpf (cleavage stage); (b) 6 hpf (early
gastrula stage); (c) 12 hpf (early segmentation stage); (d) 21 hpf (late
segmentation stage) and (e) 48 hpf (hatching stage). (B) Representative optical
images of normally developed zebrafish observations after acute treatment for
stages I - IV, (a) 24 hpf (late segmentation stage); (b) 48 hpf (hatching stage); (c)
72 hpf (pharyngula stage); (d) 96 hpf larvae and (e) 120 hpf fully developed
larvae. Note that observations for stage V began at (c-e). Scale bar = 500 pm.
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Figure 16. Characterization of Ag NPs in zebrafish embryos using DFOMS.
Representative optical images of (A) stage I (cleavage stage) embryo, (B) stage
II (early gastrula stage) embryo, (C) stage III (early segmentation stage) embryo,
(D) stage IV (late segmentation stage) embryo, and (E) stage V (hatching stage)
larvae. Areas where single Ag NPs were characterized, in the (a) extra-surface
of the chorion layers (CL); (b) in the chorion space (CS) and (c) in the inner mass
of the embryo (IME), as indicated by the squares.

Note that only (a) was

characterized in stage V due to the movement of the zebrafish larvae at this
stage. Scale bar = 500 pm. (F) Representative LSPR spectra of single Ag NPs
observed in the CL showing multiple colors (blue, green, and red) are present,
with peak wavelengths (Amax) at 490 nm (blue) (FWHM = 33 nm), 560 nm (green)
(FWHM = 34 nm), and 610 nm (red) (FWHM = 40 nm).
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of Ag NPs at each different stage of embryonic development and determined that
NPs entered the chorion at each stage regardless of the stage of development.
Single Ag NPs found in the embryonic chorion to be characterized were brought
into focus and the LSPR spectra were determined after suitable background
subtraction. Spectra of control embryos were measured in an identical manner
to ensure that the optical property of the embryonic tissue doesn't overlap with
that of the Ag NPs. A representative result of LSPR spectra is shown in Figure
16F.
We employed the concept of 2D mean-square-displacement (MSD) and
diffusion models (e.g., directed, simple and stationary Brownian diffusion)26,27 to
investigate the diffusion trajectory of single NPs in each embryonic stage of
development following the entry into embryos and inside embryos. To follow the
diffusion of single NPs inside different stage embryos in real-time, we used real
time square-displacement (RTSD) (diffusion distance at a given time interval),
instead of average (mean) of square-displacement over time, because the
diffusion coefficient could vary as single NPs diffuse in embryos. Doing this
allowed the probing of diffusion of single NPs and viscosity of different areas of
the embryonic fluid environment, such as the chorionic space or the inner mass
of the embryo in each different stage embryo in real-time.

The diffusion

coefficient (D) of single NPs in simple Brownian motion is calculated by dividing
the slope of a linear plot of real-time square-displacement versus time by 4
(Note: RTSD = 4DAt).
Representative optical images and diffusion trajectories of single Ag NPs
trapped inside the pores of the chorion layers (CL) at the interface with egg-water
and analysis of these diffusion trajectories using the real-time squaredisplacement method for each developmental stage are shown in Figure 17. The
results illustrate that as single Ag NPs make several attempts to enter the CL,
their trajectory and diffusion patterns are constrained (Fig. 17, A-E, (a-c)),
suggesting that the NPs dock into the chorion pores, which halts their normal
trajectory and diffusion patterns.

The representative D values of the green Ag
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Figure 17. Characterization of transport and diffusion trajectories of single
Ag NPs in acute treatment stages I - V at the chorion layers (CL).
Representative (a) optical images of the interface of the chorion with egg-water,
where single green Ag NPs (dashed circles) from outside chorion (OC) through
the pores (outlined in (C) by the dashed square) of the CL, represented by the
dashed lines, were monitored for the (b) diffusion trajectory and (c) real-time
square displacement (RTSD) as a function of time for stages I - V. (A) Stage I
exhibits constrained motion with D = 2.65 x 10"10± 2.43 x 10"10cm2 s"1. Scale bar
= 10 pm (a) and 400 nm (b). (B) Stage II shows constrained motion with D =
2.26 x 10"10 ± 2.08 x 1O~10cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b). (C)
Stage III illustrates constrained motion with D = 7.54 x 10"1°± 9.77 x 10~10cm2 s~1.
Scale bar = 10 pm (a) and 800 nm (b). (D) Stage IV displays constrained motion
D = 8.12 x 10"10 ± 0.12 x 10~10 cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b).
(E) Stage V demonstrates constrained motion with D = 6.04 x 10"10 ± 8.02 x 10"
10cm2

s"1. Scale bar = 10 pm (a) and 200 nm (b).
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NPs for stages I through V were (2.65 ± 2.43) x 10"10, (2.26 ± 2.08) x 10"10, (7.54
± 9.77) x 10"10. (8.12 ± 0.12) x 10 *10, and (6.04 ± 8.02) x 10~10 cm2 s'\
respectively. The data for stages I through V all showed similar findings and this
was in accordance with our previous recorded diffusion data.11 We were able to
track the entry of individual nanoparticles into the chorion of each developmental
stage.
Once the Ag NPs are inside the chorionic space (in-between the CL or
inner mass of the embryo (IME)) we characterized the D values of the NPs (Fig.
18) to determine the possible variation of D values due to the different viscosities
of the embryonic environment during that time of development. The D values are
inversely proportional to their radius, as described by the Stoke-Einstein
equation, D = kT/(6nr|a), showing that the D depends on the viscosity of
environment (ti) and the radius (a) of solute (NP).28,29 In our previous studies,
the diffusion coefficients of the given color (radius) of NPs in embryos were
studied and compared with those in egg-water, showing that the various diffusion
coefficients observed in three different parts of embryos were due to the viscosity
of embryonic environment. Simple diffusion (not active transport) with slower
diffusion rates than those in egg-water, demonstrate that single Ag NPs diffuse
into the chorionic space via passive diffusion and that the viscosity of the
chorionic space is higher than that of egg-water.11,13
There was a difference in the characterized trajectories and D values
dependent on the stage of development in the chorionic space (Fig. 18, A-D, (ac)). Stage I through IV, characterization of single NPs in the chorion space, all
displayed simple Brownian diffusion with representative D values of green NPs of
(3.35 ± 1.15) x 10"9, (7.29 ± 5.36) x 10"10, (3.31 ± 2.05) x 10'10 and (9.82 ± 3.96) x
10"10cm2 s"\ respectively. Stage I D values were higher than the D values of
stage II through IV suggesting that the environmental viscosity in stages I is
lower. This is consistent with literature in that during this period of development
(stage I) gene expression has been found to be lower as compared to stages II -
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Figure 18. Characterization of transport and diffusion trajectories of single
Ag NPs in the chorion space (CS) in acute treatment stages I - V.
Representative (a) optical images of the CS, where single green Ag NPs (dashed
circles) in-between the CL and the inner mass of the embryo (IME), represented
by the dashed lines were monitored for the (b) diffusion trajectory and (c) real
time square displacement (RTSD) as a function of time for stages I - V. (A)
Stage I exhibits simple Brownian motion with D = 3.35 x 10"9± 1.15 x 10"9cm2 s"1.
Scale bar = 10 pm (a) and 1 pm (b). (B) Stage II shows simple Brownian motion
with D = 7.29 x 10"10 ± 5.36 x 10"10cm2 s"1. Scale bar = 10 pm (a) and 1 pm (b).
(C) Stage III illustrates simple Brownian motion with D = 3.31 x 10"10± 2.05 x 10"
10cm2

s"1. Scale bar = 10 pm (a) and 400 nm (b). (D) Stage IV displays simple

Brownian motion with D = 9.82 x 10"10 ± 3.96 x 10"10cm2 s~1. Scale bar = 10 pm
(a) and 1 pm (b).
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IV.56 The lower expression of genes at this time would indicate that there are
fewer proteins being translated at this time and the biomolecule content in the
chorion space would be less resulting in a less viscous environment, which is
consistent with a higher diffusing rate observed in stage I. In stages II and IV the
diffusion appears restricted and the D values are lower suggesting that the
viscosities of the chorion space of the embryonic environment are more
concentrated during these stages of development.

The increased viscosity

correlates with these periods of development because during stage II many
genes are starting to be expressed and in stage III and IV many more genes are
being expressed during the segmentation period to aid in the development of the
organ systems and require many signaling pathways and biomolecules to
complete proper development.56 The trajectories in the chorionic space (Fig. 18,
A-D, (b)) also varied with each stage demonstrating that there are different
viscosities and fluid flow dynamics of the changing embryonic environment
during development. We were not able to accurately characterize diffusion and
trajectories of the NPs in the chorionic space for the stage V embryos due to the
movement of the live embryo.
We also characterized the diffusion coefficients of the NPs at the surface
of the inner mass of the embryo (IME). Representative diffusion trajectories of
single Ag NPs at the surface of the IME and analysis of these diffusion
trajectories

using

the

real-time

square-displacement method

for

each

developmental stage are shown in Figure 19, A-D (a, b).. The results illustrate
that as single Ag NPs make several attempts to enter the embryonic mass their
diffusion patterns are confined (Fig. 19, A-D (c)), suggesting that the NPs come
in contact with the developing embryonic mass, which arrests their normal
diffusion. The representative D values of green NPs for stages I through IV were
(3.07 ± 0.22) x 10"10, (9.73 ± 7.19) x 10'10, (9.91 ± 8.35) x 10'10and (6.79 ± 3.27) x
10"10 cm2 s"1, respectively. Again, we were not able to accurately characterize
diffusion and trajectories of the NPs in the inner embryonic mass for the stage V
embryos due to the movement of the live embryo.
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Figure 19. Characterization of transport and diffusion trajectories of single
Ag NPs in the inner mass of the embryo (IME) in acute stages I - V.
Representative (a) optical images of the IME, represented by the dashed lines
where single green Ag NPs (dashed circles), were monitored for the (b) diffusion
trajectory and (c) real-time square displacement (RTSD) as a function of time for
stages I - V. (A) Stage I exhibits constrained motion with D = 3.07 x 10"10± 0.22
x 10"10cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b). (B) Stage II shows
constrained motion with D = 9.73 x 10"10± 7.19 x 10"10cm2 s"1. Scale bar = 10 pm
(a) and 400 nm (b). (C) Stage III illustrates constrained motion with D = 9.91 x
10"10 ± 8.35 x 10"10cm2 s"1. Scale bar = 10 pm (a) and 100 nm (b). (D) Stage IV
displays constrained motion with D = 6.79 x 10~10 ± 3.27 x 10~10 cm2 s"1. Scale
bar = 10 pm (a) and 600 nm (b).
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Concentration-dependent developmental stage biocompatibility
D. rerio embryos exposed to sub-lethal concentrations of Ag NPs at select
stages revealed that NPs induced death, as well as a variety of morphological
defects and the number of different types of defects and the severity of each
increased with increasing concentration of NPs. Stage I resulted in an increasing
percentage of deformities in Ag NP treated embryos as the concentration was
increased (Fig. 20A) with a critical concentration at 0.5 nM. In stage I even
exposure to the lowest concentration produced abnormalities.

At higher

concentrations, an increasing percentage of Ag NP treated embryos died;
correspondingly, recovery of viable abnormalities also declined. At the highest
tested concentration, a majority of embryonic death was observed (Fig. 20A) with
the critical concentration at 0.06 nM.
Embryos treated in stage II had high rate of death but did not show any
signs of deformities (Fig. 20B) correlating with increasing NP concentration
having a critical concentration at 0.2 nM. This stage appeared sensitive to the
treatment with NPs causing death of the embryos. This was specific for this
stage of development and most likely due to that during this stage of
development the embryos are undergoing vast cellular movements and
establishment of the early organ systems.53,54 During this period the germ layers
of the embryos are also being established, the ectoderm, the mesoderm, and the
endoderm, which will become all parts of the developed organism.53,54 Stage II
of development is a time when the onset of gene expression is starting and
combined with our findings of restricted diffusion of the nanoparticles in the
chorion space, the nanoparticles are interacting with the increased proteins being
expressed in the chorion space.56

This could affect the pathways during

development causing an increase in death at this stage, which is directly related
to the increase in the NP concentration.
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Figure 20. Histograms displaying the distribution of effects resulting from
treatment with Ag NPs and the supernatant on zebrafish.
(A) Normally developed, deformed, and dead zebrafish vs. concentration of Ag
NPs in stage I. (B) Normally developed and dead zebrafish vs. concentration of
Ag NPs in stage II. Note: no deformities were observed in stage II. (C) Normally
developed, deformed, and dead zebrafish vs. concentration of Ag NPs in stage
III. (D) Normally developed, deformed, and dead zebrafish vs. concentration of
Ag NPs in stage IV.

(E) Normally developed and dead zebrafish vs.

concentration of Ag NPs for stage V. Note: no deformities were observed in
stage V.

(F) Normally developed and dead zebrafish vs. concentration of

supernatant removed from Ag NP washing. Note: no deformities were observed
in supernatant treatment.
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Stage III treatment resulted in an increasing percentage of deformities as
the concentration was increased (Fig. 20C) with a critical concentration at 0.07
nM. The critical concentration is the minimum concentration needed to affect at
least 50% of the normal zebrafish population. Exposure to the lowest
concentration in stage III produced no abnormalities. At higher concentrations,
an increasing percentage of Ag NP treated embryos died and equally the
recovery of viable abnormalities for stage III also declined. At the highest tested
concentration, a total embryonic death was observed (Fig. 20C) with the critical
concentration at 0.02 nM.
Stage IV treated embryos resulted in increased deformities with the lowest
concentration

and

remained

consistently

constant

throughout

Ag

NP

concentration rises (Fig. 20D). The critical concentration was determined to be
0.02 nM.

In stage IV even exposure to the lowest concentration produced

abnormalities. At higher concentrations, a small increasing percentage of Ag NP
treated embryos died. At the higher tested concentrations in stage IV, a majority
of embryonic death was observed (Fig. 20D) with the critical concentration at
0.02 nM.
Stage V resulted in no morphological defects and only a slight increase in
death rate (Fig. 20E) with a critical concentration at 0.07 nM. This is possibly
due to that during stage V, the embryo is in the hatching stage and finishing its
development.53 Untreated control embryos for stages I through V (0.00 nM)
produced no abnormal embryos and embryo viability was within normal limits
(Fig. 20A-F). Control embryos exposed to (nanoparticle-free) supernatant from
the NP washing process showed minimal levels of toxicity at all tested
concentrations (Fig. 20F).
The effective dose for our acute studies was determined from our previous
chronic studies.11 We treated stage I through V embryos acutely with various
concentrations of Ag NPs (0 - 0.7 nM). Embryos were carefully monitored post
treatment at 24, 48, 72, 96, and 120 hpf (Fig. 15B). We examined the defects
associated with treatment of developing embryos with Ag NPs at each treated
embryo developmental stage. Many morphological defects were observed in the
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developing zebrafish, including abnormal finfold and tail development, cardiac
malformation, yolk sac edema and acephaly as shown in Figure 21. Stages I, III,
and IV all had defects whereas; stage II had high rate of death but did not show
any signs of deformities. Stage V did not show any signs of abnormalities and
death only slightly increased. The shared abnormality among stages I, III, and IV
treated embryos was finfold abnormalities, typically affecting the median finfold
region (Fig. 21A - C (a)). In normally developing embryos, the median finfold is a
clear, thin membrane around the entire trunk region containing unsegmented fin
rays. In treated embryos at stage I, III, and IV, the tissue structure of the finfold
was disorganized and in the more severe cases, the shapes of the finfold and the
developing fin rays were altered. Treated embryos from stages I, III, and IV also
displayed as the second shared defect, an abnormal tail (spinal cord) flexure
phenotype (Fig. 21A - C (b)). This defect was often accompanied by tissue
abnormalities of the finfold. In normal developing embryos, the notochord and
spinal cord develop straight to the posterior-most tip of the tail. In the treated
embryos for these stages however, the tail region was flexed to some extent. In
the more severely flexed embryos, the flexure was extreme and the overall
length of the tail was reduced (Fig. 21A (b)).

The tail flexure defect also

increased in severity with increasing NP concentration.
The types and majority of defects observed differed according to the
developmental stage at treatment.

Embryos treated with the higher Ag NP

concentrations (0.06 and 0.6 nM) in stage I presented with acephaly, or absence
of a developed head (Fig 21A (e, f)). The embryos had a small amount of tissue
where the head would normally develop. The tissue was not a fully formed head
but rather an irregular formed mass of tissue. The severe cases of acephaly
recovered from the treatment were only found to occur in stage I of development
and not in stages III and IV. This is most likely due to the specific time of
development because in stage I of development, the cells are still in the process
of cleaving to lay out the map to form the head and caudal regions of the
developing organism. If cells do not divide properly in the head or tail region of
the body axis, it will not fully develop. Previous studies have demonstrated that
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Figure 21. Representative optical images of deformities observed in stages
I, III, and IV after acute treatment with Ag NPs.
(A) Stage I deformed zebrafish displaying (a) Unfold abnormality; (b) tail/spinal
cord flexure; (c) cardiac malformation; (d) yolk sac edema and (e, 0 acephaly.
(B) Stage III deformed zebrafish displaying (a) finfold abnormality; (b) tail/spinal
cord flexure; (c) cardiac malformation and (d) yolk sac edema. (C) Stage IV
deformed zebrafish displaying (a) finfold abnormality; (b) tail/spinal cord flexure;
(c) cardiac malformation and (d) yolk sac edema. Scale bar = 500 pm.
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inhibiting p38 kinase activity resulted in blastomeres on one side of the
embryonic mass not to divide.57 In stage I treated embryos, the deformity type
that was observed the most was found to be finfold abnormality (Fig 21A (a)).
Treated embryos from stage I displayed an abnormal tail flexure phenotype,
cardiac malformation, and edema, or swelling, of the yolk sac region as the
second most common defect (Fig 21A (b-d)). In normally developing embryos,
the yolk sac region is a bulbous area containing yolk that provides nutrients to
the developing embryo and during the later developmental process, the yolk sac
shrinks. In the affected treated embryos at stage I, however, the yolk sac region
was swollen and enlarged.

Embryos at stage I exposed to Ag NPs also

displayed edema of the pericardial sac region. In contrast to normal embryos, in
the stage I treated embryos; the pericardial sac region was swollen and enlarged
(Fig 21A (c)). In severe cases, the pericardial sac was extremely large and the
cardiac ventricle was decreased in size. Finally, a minority of treated embryos
for stage I displayed the acephaly defect at high concentrations (Fig 21A (e, f)).
Embryos treated in stage III presented with no acephaly displaying that
the acephaly deformity was characteristic of stage I treatment only. In treated
embryos at stage III, the most common types of deformities observed were
finfold abnormality, abnormal tail flexure phenotype, cardiac malformation, and
edema, or swelling, of the yolk sac region (Fig. 21B (a-d)). The findings of tail
deformity correlates with stage III of development because this is when embryos
begin somitogenesis and notochord formation, which is important for proper
development of the axial skeleton, the vertebrate spinal column, and the skeletal
muscle.55 Embryos at stage III exposed to Ag NPs also displayed edema of the
pericardial sac region. In contrast to normal embryos, in the stage III treated
embryos; the pericardial sac region was swollen and enlarged (Fig. 21B (c)). At
the highest doses, the pericardial sac was extremely large and the cardiac
ventricle was decreased in size.
Embryos treated in stage IV presented with no acephaly and the most
common type of deformity was not finfold abnormality, as in stages I and III, but
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was observed to be cardiac malformation (Fig. 21C (c)). This is most likely due
the stage of development during treatment with the NPs, because during stage
IV of development, the heart is being formed and is preparing for its first
contraction.53 A majority of embryos at stage IV exposed to Ag NPs displayed
edema of the pericardial sac region. At the highest doses, the pericardial sac
was extremely large and the cardiac ventricle was decreased in size (Fig. 21C
(c)). Treated embryos from stage IV also displayed as the second most common
defects, an abnormal finfold development, tail flexure phenotype, and edema, or
swelling, of the yolk sac region similar to those findings for stages I and III
treatment (Fig. 21C (a, b, d)).
Finfold abnormalities accounted for majority of recovered events at stages
I and III (Fig. 22A, B).

At higher doses for stages I and III, an increasing

percentage of events (but still a minority) included cardiac malformation, yolk sac
edema, and tail flexure deformities (Fig. 22A, B).

Cardiac malformation, at

44.1%, accounted for majority of recovered events at stage IV (Fig. 22C). At
higher doses for stage IV, an increasing percentage of yolk sac edema occurred
and other minority events included finfold abnormality and tail flexure deformities
(Fig. 22C).
Possible reasons for the high dependence of type and severity of defects
on the stage of development and concentration of NPs could be due to the
following: (i) The NPs enter inside the chorion space of the embryo during the
specific stage of development and affect the specific proteins, signaling, and
developmental pathways during that period of development, (ii) An increase in
number of NPs inside the chorion space of the embryo during the specific stage
of development increases the altering effects of the protein, signaling, and
developmental pathways during development increasing severity of the deformity
observed or death.
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Figure 22. Histograms of the types of deformities vs. the percentage of
zebrafish.
After acute treatment at each concentration of Ag NPs, five types of deformities
in (A) stage I and four types of deformities in (B) stage III and in (C) stage IV
were observed.
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Our results describe a range of developmental defects and death following
exposure of developing zebrafish embryos to nanomolar concentrations of Ag
NPs at particular embryonic stages of development.

Specific developmental

pathways of embryonic development are still unknown, such as, differentiation
into specialized tissues and organs, specifically how cells communicate with
each other, how they become committed to a certain fate, and how they
formulate a pattern to become a structure.54,56 Stage dependent developmental
responses to Ag NPs, shown here, in a dose dependent manner, demonstrates
the possibility of being able to pick specific developmental pathways to create
particular phenotypes and as potential developmental therapeutic agents to treat
specific disorders and generate specific developmental mutation in zebrafish, by
alteration of the time of application of the NPs.

SUMMARY
In summary, we examined the transport and diffusion of single Ag NPs in
vivo at specific stages of development and the defects associated with treatment
at specific developmental stages. Ag NPs were observed inside embryos of
every treated developmental stage, demonstrating that Ag NPs can transport
independent of the stage of the developing embryos and can be administered
without outside influence, such as microinjection.

Ag NPs can be used in

developmental stage treatment in vivo assays for study of nanomaterials and
their role in developmental biology. The transport and diffusion of NPs in the
chorion space demonstrated that the viscosity of the developing embryonic
environment could be documented at each stage of development using single NP
optics. An increase in embryonic environmental viscosity and NP concentration
correlated to an increase in death, which demonstrated NP interaction with
transcribed biomolecules in the chorion space during development.

Many

morphological defects were observed in the developing embryo, including
acephaly, yolk sac edema, abnormal finfold and tail development, and cardiac
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malformations at each stage of development, corresponding to the stage of
treatment. In general, the number of different types of defects and the severity of
each varied with the stage of treatment and increased with increasing dose of
NPs demonstrating the possibility of selectively targeting specific embryonic
developmental pathways by altering the stage of development and dose of NPs
for developmental therapeutic studies. The investigation of transport, diffusion,
and biocompatibility of nanomaterials in specific stages of development of
embryos at single NP level can offer new knowledge about the developmental
processes and environment, and provide new insights into the mechanics of the
developing embryo as well as aid in the finding for functional nanodevelopmental treatments for various disorders in early development.

METHODS
Synthesis and Characterization of Ag NPs
We synthesized Ag NPs (13.1 ± 2.5 nm), as we described previously.11,13,
58

The design and construction of our DFOMS for imaging of single Ag NPs in

solution and in single embryos has been described in detail in our previous
studies.11,13,15,58"64
Treatment and monitoring of Zebrafish Embryos
Wildtype (WT) adult zebrafish (Aquatic Ecosystems) were maintained,
bred, and collected, as described previously.11,59 16 embryos were tested per
concentration, per stage of development for 2 hours in NPs; each experiment
was repeated 3 times, totaling 48 embryos analyzed per concentration, per stage
of development. Each developmental stage of embryos in the wells was directly
imaged as described previously.
Study and Characterization of Transport and Biocompatibility of NPs
Stage II through V living embryos that had been incubated with 0.2 nM
NPs for a given time (0-2 hours) were carefully rinsed with Dl water to remove
external NPs, placed in a self-made microwell containing Dl water, and
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immediately imaged to investigate the transport of NPs into embryos or untreated
embryos were placed in a self-made microwell containing Dl water to image the
diffusion and transport of NPs inside the embryos in real-time using our DFOMS
by adding the Ag NPs directly to the microwell.
To study the dose-dependent effects of NPs on embryonic development, a
dilution series of washed Ag NP solutions (0, 0.02, 0.04, 0.05, 0.06, 0.07, 0.18,
0.35, 0.53, 0.62, and 0.66 nM) were incubated acutely with 5 stages of embryos
in egg-water for 2h. Each experiment was carried out at least 3 times and total
number of embryos at 48 was studied for each individual concentration to gain
representative statistics.

NP concentrations were calculated as described

previously.11 Embryos in egg-water in the absence of NPs and in the presence
of supernatant were placed in two rows of the 24-well plates as control
experiments to probe the effects of possible trace chemicals from NP synthesis.
The embryos in the 24-well plates were incubated at 28.5°C, and directly
observed at room temperature using an inverted Zeiss Axiovert microscope
equipped with a digital color camera at 24, 48, 72, 96, and 120 hpf.
Data Analysis and Statistics
A minimum of 100 Ag NPs was imaged and characterized for each
measurement of their sizes and stability in egg-water using HRTEM and DFOMS.
A minimum of 300 NPs in total was studied for each sample via three repeated
measurements.

For real-time imaging of diffusion of single NPs into and in

embryos over time, a minimum of 16 embryos was studied for each given
concentration.

For study of dose-dependent effects of NPs on embryonic

development, a total number of 48 embryos were studied for each NP
concentration and each control experiment over 120 hpf with a minimum of 12
embryos studied in each measurement.
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CHAPTER IV
STUDY OF CHARGE DEPENDENT TRANSPORT, BIOCOMPATIBILITY AND
TOXICITY OF 12 NM SILVER NANOPARTICLES USING ZEBRAFISH
EMBRYOS

INTRODUCTION
Drug delivery using nanotechnology has become an exciting new area of
interest for new innovative ways to use nanomaterials as drug delivery vehicles
for both targeting and sensor of cellular changes in living systems and delivery of
drugs to specific cells and tissues30'63,65^9J0. New drug delivery approaches are
using nanotechnology as a type of nanomedicine to establish an earlier diagnosis
and a new safer treatment option by using direct delivery methods to single cells
for many diseases, including cancers71.

With the potential for use of

nanomaterials in a living system to directly target diseased ridden cells, it is
important to explore the important biophysicochemical interactions the
nanomaterials can have in and on living biological system. There are many
different biophysicochemical factors that are important for how nanomaterials
interact with a biological system. Size, shape, surface charge (zeta potential),
functional groups, and ligands can all affect how a nanomaterial will behave and
how it will affect the delivery or function of a drug to a target cell or diagnosis
sensor system in a living in vivo system72,

73, 30, 74.

To understand these

interactions in more detail it is important to look at each factor and investigate
how nanomaterials behave in a living in vivo system to anticipate potential drug
delivery response. The biophysicochemical characteristics of nanoparticles can
determine how biocompatible a nanoparticle will be in an in vivo system72.
Surface charge has been shown to have an impact on the biocompatibility of a
nanoparticle to a living system72.
In this study we focused on how surface charge (zeta potential) influences
how a single silver (Ag) nanoparticle transports and diffuses in a living zebrafish
embryo system in real-time. We also examined the biocompatibility the different

r
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surface charged Ag nanoparticles had on the zebrafish system and how it
influenced the embryonic development.

Interaction of surface charged

nanoparticles in a biological system, especially an embryonic developing system,
is an interesting area of nanotechnology research. Greater understanding of
developmental biology is crucial and utilizing nanoparticle technology and
understanding the biophysicochemical interactions will allow more information to
explore unknown mechanisms during development.
It is not known whether Ag nanoparticles with different surface charges
can enter the zebrafish embryo and what impact will they have on the developing
system.

Previous studies with gold nanoparticles on cells show strong

correlation of surface charge and related toxicity75,76 Nanoparticles have unique
surface chemistry which allows them to be conjugated with biomaterial (DNA,
peptide, drugs etc,) for biomedical clinical purposes so it is important to
investigate surface charge transport, diffusion, and biocompatibility on a living
system77'78.
We synthesized uniform Ag nanoparticles with three different surface
charges and conducted studies for their transport and biocompatibility in
developing embryos. Surface charge is important because it influences every
aspect of nanoparticle function, uptake mechanisms and nanoparticle clearance.
To our knowledge, there has been no significant research done to study the
impact of surface charge of nanoparticles on the biocompatibility, toxicity, and the
transport of these nanoparticles in an in vivo model system. There are however
toxicity and biocompatibility studies done with other nanomaterials using cells as
the model organism79"84. Also many studies have used nanoparticles as delivery
agents in living systems85.

RESULTS AND DISCUSSION
Synthesis and Characterization of Stability of Ag Nanoparticles
We synthesized sphere shaped Ag NPs as described previously and
conjugated them with three different types of peptides, CALNNE (-), CALNNS

(~0), CALNNK (+), producing NPs with different surface charges, as
demonstrated in Figure 23 enabling the study of key surface charge dependent
transport, diffusion, and biocompatibility to determine their behavior in vivo,
including morphological responses and concentration dependent morphological
responses, for potential use as drug delivery systems or developmental
intermediates for biomedical applications70,

80.

We characterized the zeta-

potential of our peptide Ag nanoparticles and determined the surface charge for
Ag-CALNNK (+), Ag-CALNNS(-O), and Ag-CALNNE(-) to be 2.96 ± 0.19, - 5.04 ±
0.09, -11.94 ± 0.94, respectively (Fig. 23B).
We further characterized the purified Ag NPs conjugated with CALNNK (+),
CALNNS (~0), and CALNNE (-) using transmission electron microscopy (TEM)
and dark field optical microscopy and spectroscopy (DFOMS) (Fig. 24 - 26). The
representative TEM image and TEM distribution for Ag-CALNNK (+) NPs in Fig.
24 indicate that the majority of the NPs are spherical in shape and the average
size is 11.5 ± 2.9 nm (Fig. 24A-B). The representative DFOM image shows that
NPs are blue and green (Fig. 24C). The LSPR spectra of single Ag-CALNNK (+)
NPs (blue and green), had peak wavelengths (Amax) at 508 nm, 554 nm and 585
nm (Fig. 24D).
For Ag-CALNNS (~0) NPs in Fig. 25 indicate that the majority of the NPs
are spherical in shape and the average size is 12.3 ± 2.7 nm (Fig. 25A-B). The
representative DFOM image shows that NPs are blue and green (Fig. 25C). The
LSPR spectra of single Ag-CALNNS (~0) NPs (blue and green), had peak
wavelengths (Amax) at 508 nm, 560 nm and 581 nm (Fig. 25D).
For Ag-CALNNE (-) NPs in Fig. 26 indicate that the majority of the NPs are
spherical in shape and the average size is 11.3 ± 2.5 nm (Fig. 26A-B). The
representative DFOM image shows that NPs are blue and green (Fig. 26C). The
LSPR spectra of single Ag-CALNNS (~0) NPs (blue and green), had peak
wavelengths (Amax) at 508 nm, 560 nm and 581 nm (Fig. 26D).
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Figure 23. Illustration of synthesis and respective zeta-potentials of Agpeptide NPs for charge dependent transport studies in developing
zebrafish embryo.
(A) Illustration of (a) Ag-CALNNE (-), (b) Ag-CALNNS (~0), and (c) Ag-CALNNK
(+) design. (B) Zeta-potential of (a - c) in (A) was -11.94 ± 0.94 mV, -5.04 ± 0.09
mV, and +2.96 ±0.19 mV, respectively.
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Figure 24. Characterization of size of Ag NPs and optical properties and
stability of Ag-CALNNK (+) NPs.
(A) Representative HRTEM image demonstrates the size and spherical shape of
single Ag NPs. Scale bar =10 nm. (B) Histogram of size distribution of Ag NPs
measured by HRTEM shows the average size to be 11.5 ± 2.9 nm.

(C)

Representative dark-field optical image of single Ag-CALNNK (+) NPs (a-c)
shows that NPs are blue and green. Scale bar = 2 |jm. (D) LSPR

spectra

of

single Ag-CALNNK (+) NPs (blue and green), with peak wavelengths (Amax) at (a)
508 nm (FWHM = 72 nm), (b) 554 nm (FWHM = 93 nm) and (c) 585nm (FWHM =
99nm).

r

61

50%
e
m
Q.

B

25%

k

R

0%

ymymymy

y l£l>l£

6 8 10 12 14 16 18 20
Diameter (nm)
200

100
O) a»

450

550
650
Wavelength (nm)

750

Figure 25. Characterization of size of Ag NPs and optical properties of AgCALNNS (~0) NPs.
(A) Representative HRTEM image demonstrates the size and spherical shape of
single Ag NPs. Scale bar = 20 nm. (B) Histogram of size distribution of Ag NPs
measured by HRTEM shows the average size to be 12.3 ± 2.7 nm.

(C)

Representative dark-field optical image of single Ag-CALNNS (~0) NPs (a-c)
shows that NPs are blue and green. Scale bar = 2

(D) LSPR

spectra

of

single Ag-CALNNS (~0) NPs (blue and green), with peak wavelengths (Amax) at
(a) 508 nm (FWHM = 68 nm), (b) 560 nm (FWHM = 88 nm) and (c) 581 nm
(FWHM = 101 nm).
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Figure 26. Characterization of size of Ag NPs and optical properties of AgCALNNE (-) NPs.
(A) Representative HRTEM image demonstrates the size and spherical shape of
single Ag NPs. Scale bar = 20 nm. (B) Histogram of size distribution of Ag NPs
measured by HRTEM shows the average size to be 11.3 ± 2.5 nm.

(C)

Representative dark-field optical image of single Ag-CALNNE (-) NPs (a-c)
shows that NPs are blue and green. Scale bar = 2 |jm. (D) LSPR

spectra

of

single Ag-CALNNE (-) NPs (blue and green), with peak wavelengths (Amax) at (a)
506 nm (FWHM = 69 nm), 555 nm (FWHM = 98 nm) and (d) 595 nm (FWHM =
111 nm).

63

We further characterized the stability of the purified Ag NPs conjugated
with CALNNK (+), CALNNS (~0), and CALNNE (-) in egg-water embryo media
(1.2 mM NaCI) for 120 hrs using DFOMS, UV-vis spectroscopy, and dynamic
light scattering (DLS) (Fig. 27 - 29). The number of NPs/image (20 images) for
Ag-CALNNK (+) indicate at to, 12h, 24h, 48h, 72h, 96h and 120h were 117 ± 3,
115 ± 3, 116 ± 2, 115 ± 3, 113 ± 4, 115 ± 4 and 112 ± 3, respectively. This
indicated that the NPs remained unchanged as NPs were incubated with eggwater and were very stable over a period of 120h (Fig. 27A). The representative
UV-vis absorption spectra for Ag-CALNNK (+) well-dispersed in egg-water at
28°C for (a) Oh and (b) 120h demonstrates the peak absorbance at 0.083 and
peak wavelength at 406 nm and they remain unchanged for 120h (Fig. 27B).
The representative size distribution of stability of Ag-CALNNK (+) NPs in eggwater media using DLS indicate at Oh the size is (a) 11.2 ± 2.5 nm and at 120h is
(b) 11.3 ±2.6 nm (Fig. 27C).
For Ag-CALNNS (~0) (Fig. 28), the number of NPs/image (20 images)
indicate at to, 12h, 24h, 48h, 72h, 96h and 120h were 115 ± 3, 116 ± 4, 117 ± 3,
117 + 4, 116±4, 115±3 and 115 ± 3, respectively. This indicated that the # of
NPs remained unchanged as NPs were incubated with egg-water and were very
stable over a period of 120h (Fig. 28A). The representative UV-vis absorption
spectra for Ag-CALNNS (~0) well-dispersed in egg-water at 28°C for (a) Oh and
(b) 120h demonstrates the peak absorbance at 0.158 and peak wavelength at
406 nm and they remain unchanged for 120h (Fig. 28B). The representative size
distribution of stability of Ag-CALNNS (~0) NPs in egg-water media using DLS
indicate at Oh the size is (a) 12.8 ± 2.8 nm and at 120h is (b) 13.3 ± 2.9 nm (Fig.
28C).
For Ag-CALNNE (-) (Fig. 29), the number of NPs/image (20 images)
indicate at to, 12h, 24h, 48h, 72h, 96h and 120h were 113 ± 3, 111 ± 2, 111 ± 2,
110±4, 113 ± 2, 112±3 and 111 ±3, respectively. This indicated that the # of
NPs remained unchanged as NPs were incubated with egg-water and were very
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Figure 27. Characterization of stability of Ag-CALNNK (+) NPs.
(A) The number of NPs/ image (20 images) at to, 12 h, 24 h, 48 h, 72 h, 96 h and
120 h were 117 ± 3, 115 ± 3, 116 ± 2, 115 ±3, 113 ±4, 115 ±4 and 112 ±3. (B)
Representative UV-Vis absorption spectra of Ag-CALNNK (+) NPs well-dispersed
in egg-water at 28°C for (a) 0 and (b) 120 h shows the peak absorbance at 0.083
and peak wavelength at 406 nm (FWHM = 100 nm) and they remain unchanged
for 120 h.(C) Histograms of size distribution of stability of Ag-CALNNK (+) NPs in
egg-water media using DLS, (a) 11.2 ± 2.5 nm at 0 h and (b) 11.3 ± 2.6 nm at
120 h.
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Figure 28. Characterization of stability of Ag-CALNNS (~0) NPs.
(A) The number of NPs/ image (20 images) at to, 12 h, 24 h, 48 h, 72 h, 96 h and
120 h were 115 ±3, 116±4, 117 ± 3, 117±4, 116±4, 115±3and 115±3. (B)
Representative UV-Vis absorption spectra of Ag-CALNNS (~0) NPs welldispersed in egg-water at 28°C for (a) 0 and (b) 120 h shows the peak
absorbance at 0.158 and peak wavelength at 406 nm (FWHM = 101 nm) and
they remain unchanged for 120 h. (C) Histograms of size distribution of stability
of Ag-CALNNS (~0) NPs in egg-water media using DLS, (a) 12.8 ± 2.8 nm at 0 h
and (b) 13.3 ± 2.9 nm at 120 h.
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Figure 29. Characterization of stability of Ag-CALNNE (•) NPs.
(A) The number of NPs/ image (20 images) at to, 12 h, 24 h, 48 h, 72 h, 96 h and
120 h were 113 ±3, 111 ±2, 111 ±2, 110 ±4, 113 ±2, 112 ±3 and 111 ±3. (B)
Representative UV-Vis absorption spectra of Ag-CALNNE (-) NPs well-dispersed
in egg-water at 28°C for (a) 0 and (b) 120 h shows the peak absorbance at 0.091
and peak wavelength at 401 nm (FWHM = 99 nm) and they remain unchanged
for 120 h. (C) Histograms of size distribution of stability of Ag-CALNNE (-) NPs
in egg-water media using DLS, (a) 11.9 ± 2.8 nm at 0 h and (b) 12.3 ± 2.8 nm at
120 h.
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stable over a period of 120h (Fig. 29A). The representative UV-vis absorption
spectra for Ag-CALNNE (-) well-dispersed in egg-water at 28°C for (a) Oh and (b)
120h demonstrates the peak absorbance at 0.091 and peak wavelength at 401
nm and they remain unchanged for 120h (Fig. 29B). The representative size
distribution of stability of Ag-CALNNE (-) NPs in egg-water media using DLS
indicate at Oh the size is (a) 11.9 ± 2.8 nm and at 120h is (b) 12.3 ± 2.8 nm (Fig.
29C).
Transport, diffusion, and biocompatibility of nanoparticles in vivo
We treated cleavage stage (64 cell, 2.25 hours post fertilization (hpf))
zebrafish embryos without the aid of any direct intrusion and followed their
development for 120 hpf. Representative optical images of normal zebrafish
development at treatment and throughout treatment in the absence of
nanoparticles are shown in Fig. 30.
To study the transport and diffusion of single Ag NPs in developing
zebrafish embryos we incubated Ag-peptide NPs with cleavage stage embryos
and were able to directly observe and characterize their transport and diffusion in
real time using our DFOMS (Fig. 31).

This allowed us to follow NPs and

demonstrate their ability to travel through the chorion and into chorion space of
the embryo and enter the inner mass of embryo regardless of the surface charge
as shown in Figure 31B, a - c, respectively. Tracking NPs in the embryonic
environment allowed us to probe diffusion of the different surface charged NPs,
and determine the transport mechanism in an internal developing embryonic
environment in real-time.

For determining the transport mechanism of the

nanoparticles in the embryonic environment, we used the concept of twodimensional mean squared displacement (MSD) and different modes of diffusion
such as simple, directed and random Brownian motion. These models were
used to analyze diffusion trajectory of the NPs in egg-water, along the chorion
interface, in the chorion space of the developing embryo and inside the
developing embryonic mass.

Representative diffusion trajectory and plots of

single Ag-peptide NPs interacting with the pores on the chorion interface of the
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Figure 30. Representative optical images of normally developed zebrafish.
(A) 0.75 - 2.25 hpf (cleavage-stage, at the time of treatment). (B) 24 hpf (late
segmentation stage). (C) 48 hpf (hatching stage). (D) 72 hpf (pharyngula stage).
(E) 120 hpf fully developed larvae. Scale bar = 500 pm.
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Figure 31. Characterization of transport and diffusion trajectories of single
Ag-peptide NPs at the chorion layers (CL), in the chorion space (CS) and at
the inner mass of the embryo (IME).
(A) Cleavage stage embryo, 2-4 hpf, demonstrating areas that were imaged (a)
chorion interface, (b) chorion space, and (c) embryonic mass surface. Scale bar
= 500 pm. (B) Representative optical images of Ag-CALNNK (+) NPs (circles) at
the (a) CL (dashed lines), (b) inside CS and (c) at the IME. The square highlights
the chorion pores in the CL. Scale bar = 10 pm. (C) Representative diffusion
trajectories of Ag-CALNNK (+) NPs in the (a) CL, (b) CS and (c) IME. Scale bar
= 100 nm (a), 1 pm (b) and 400 nm (c). (D) Representative plots of real-time
square displacement (RTSD) as a function of time of the single green Ag-peptide
NPs in the (a) CL, (b) CS and (c) IME.
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developing embryo, in the chorion space and interacting with the inner embryonic
mass (Fig. 31C, D) demonstrate varying diffusion coefficients (D). Due to the
different embryonic environment at various locations, the diffusion coefficient can
vary. Therefore we used real time square displacement (RTSD), instead of using
the mean of the squared displacement allowing us to probe the diffusion of single
silver in real time. The D of the single silver nanoparticles in simple Brownian
motion was calculated by dividing the slope of the linear plot of the RTSD as a
function of time divided by 4 (Fig. 31D).
The results of the diffusion using the previous mentioned RTSD method
showed that at the chorion layers (CL), (i) Ag-CALNNK (+), (ii) Ag-CALNNS (~0)
and (iii) Ag-CALNNE (-) demonstrate constrained motion with D = (6.05 ± 3.77) x
10"10 cm2 s"\ (2.11 ± 2.47) x 10"10 cm2 s"1 and (1.30 ± 0.95) x 10"10 cm2 s\
respectively. In the chorion space (CS), (i) Ag-CALNNK (+), (ii) Ag-CALNNS (~0)
and (iii) Ag-CALNNE (-) demonstrate simple Brownian motion with D = (1.52 ±
0.92) x 10"9 cm2 s1, (1.40 ± 0.26) x 109cm2 s'1 and (1.62 ± 1.53) x 10~9cm2 s"1,
respectively. At the inner mass of the embryo (IME), (i) Ag-CALNNK (+), (ii) AgCALNNS (~0) and (iii) Ag-CALNNE (-) demonstrate simple Brownian motion with
D = (1.17 ± 1.48) x 10"9cm2 s \ (3.01 ± 3.81) x 10"9cm2 s 1 and (9.71 ± 7.18) x 10"
10 cm2

s"\ respectively (Fig. 31D).
Resultant data of treated normal, dead, deformed and control embryos are

shown in Figure 32. Treatment with Ag-CALNNE (-) resulted in an increase
death. When comparing the death rate of these NPs to Ag-CALNNK (+) NPs,
80% embryos died in 0.6 nM, whereas zebrafish embryos treated at similar
concentration with positive charged had higher percentage survival percentages
(Fig. 32). Deformities in Ag-CALNNE (-) NP treated embryos were seen in 0.4
nM and 0.6 nM concentrations. Death and deformities in treated embryos were
found to be concentration dependent as with increasing nanoparticles substantial
increase in death and deformities were seen in all types of charged
nanoparticles.

The supernatant was used as a control to ensure that no by-
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Figure 32. Histograms displaying the distribution of effects resulting from
chronic treatment with Ag-peptide NPs and their supernatant on zebrafish.
(A) (a) Normally developed, deformed, and dead zebrafish vs. concentration of
Ag-CALNNK (+) NPs.

(b) Normally developed and dead zebrafish vs.

concentration of supernatant (Sup) removed from Ag-CALNNK (+) NP washing
and concentration of CALNNK (+) alone. (B) (a) Normally developed, deformed,
and dead zebrafish vs. concentration of Ag-CALNNS (~0) NPs. (b) Normally
developed and dead zebrafish vs. concentration of supernatant (Sup) removed
from Ag-CALNNS (~0) NP washing and concentration of CALNNS (~0) alone.
(C) (a) Normally developed and dead zebrafish vs. concentration of Ag-CALNNE
(-) NPs.

(b) Normally developed zebrafish vs. concentration of supernatant

(Sup) removed from Ag-CALNNE (-) NP washing and concentration of CALNNE
(-) alone. Note: no deformities were observed.
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products from synthesis were contained in the NP solution and that the
treatment response was due to the exposure of the Ag NPs and not the chemical
used in the synthesis procedure. The percentage of normal zebrafish remained
high even in the highest dose of supernatant confirming that the washing
procedure carried out on Ag NPs prior to treatment and the chemical by
products are not responsible for the deformities observed (Fig. 32b).
We also examined individual defects associated with charged NPs and the
morphological defects observed in zebrafish embryos included yolk sac edema,
abnormal finfold and tail development, cardiac malformation and eye deformities
in all types of charged nanoparticle treatment (Fig. 33).
The number of defects and its severity were concentration and charge
dependent. Severe defects like yolk sac edema, cardiac abnormalities and eye/
head abnormalities were higher in Ag-CALNNE (-) NPs as compared to AgCALNNK (+) NPs. Emergence of deformities occurred more frequently in the AgCALNNE (-) NP treated embryos as compared to the zebrafish embryos treated
with the Ag-CALNNK (+) NPs.

Fewer abnormalities were seen in zebrafish

embryos treated with Ag-CALNNK (+) (Fig. 32 and 34). The most common
deformity observed was a finfold abnormality and disorganization of the finfold
tissue. In normally developed zebrafish embryos the fin rays are organized.24,53,
86

The second most common deformity observed in Ag-peptide NPs treated
zebrafish embryos was cardiac malformation.

Cardiac malformation was

displayed as the edema of the pericardial sac region (Fig. 33c). The pericardial
sac in embryos with this deformity was extremely large and cardiac arrhythmia
was also observed.

Zebrafish embryos treated with 0.6 nM Ag-CALNNE (-)

concentrations demonstrated cardiac abnormality. At similar concentrations, AgCALNNK (+), observed 0% cardiac deformities.
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Figure 33. Representative optical images of deformities observed in
zebrafish after chronic treatment with Ag-peptide NPs.
(A) Ag-CALNNK (+) NP treated zebrafish displaying (a) finfold abnormality; (b)
tail/spinal cord flexure and (c) cardiac malformation, (d) yolk sac edema and (e)
no eye formation.

(B) Ag-CALNNS (~0) NP treated zebrafish displaying (a)

finfold abnormality; (b) tail/spinal cord flexure and (c) cardiac malformation, (d)
yolk sac edema and (e) small eyes. (C) Ag-CALNNE (-) NP treated zebrafish
displaying (a) finfold abnormality; (b) tail/spinal cord flexure and (c) cardiac
malformation, (d) yolk sac edema and (e) small eyes. Scale bar = 500 |jm.
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Figure 34. Histograms of the types of deformities vs. the percentage of
zebrafish.
(A) Ag-CALNNK (+) NPs, (B) Ag-CALNNS (~0) NPs and (C) Ag-CALNNE (-)
NPs.
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Another prevalent deformity observed in treated zebrafish embryos was
yolk sac edema.

In normally developing embryos, the yolk sac region is a

bulbous area containing yolk that provides nutrients to the developing embryos
and during the later developmental process, the yolk sac shrinks24,

53, 86

In

embryos with yolk sac edema, the yolk sac region was swollen and enlarged
(Fig. 33d). In many embryos yolk sac edema was simultaneously observed with
cardiac abnormalities. Eye abnormalities, in the form of small eyes, were also
widely seen in zebrafish embryos treated with our NPs (Fig. 33e). Percentage of
eye abnormalities was significantly higher with Ag-CALNNE (-) as compared to
Ag-CALNNK (+).

While the Ag-CALNNK (+) observed only one eye/head

abnormality at 0.4nM with Ag-CALLNS (~0) and Ag-CALLNE (-) treated embryos
there was a higher frequency of eye/head abnormalities for 0.4 nM and 0.6 nM
treatment concentration. Most frequent eye abnormalities observed were small
eyes and disorganized development. All the deformities showed concentration
and charge dependent phenomenon, with increase in nanoparticle concentration
there was significant increase in overall deformities in zebrafish embryos in AgCALNNS (~0) and Ag-CALNNE (-) NPs.
Characterization of Ag nanoparticles embedded inside fully developed
zebrafish
We characterized Ag-CALNNK (+) embedded inside fully developed normal
zebrafish that were chronically treated at the concentration 0.2 nM using
DFOMS. From a transverse section (Figure 35A), we found that these Ag NPs
were embedded in multiple areas (eye and brain) of a normally developed
zebrafish (Fig. 35B, a-b, respectively). To confirm that these were NPs and not
cellular debris from the zebrafish tissue, we took LSPR spectra of the NPs in the
different areas (Fig. 35C). These results demonstrate that Ag-CALNNK (+) are
biocompatible with developing zebrafish at given concentrations.

We also

performed a control experiment by imaging tissue sections of a zebrafish that
developed in the absence of nanoparticles and did not observe the individual Ag
nanoparticles as we did in the treated zebrafish.

f
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Figure 35. Characterization of individual Ag-CALNNK (+) NPs embedded
inside a fully developed normal zebrafish using DFOMS.
(A) Optical image of a fixed transverse section of a normal zebrafish.

The

dashed rectangles highlight representative areas: (a) eye and (b) brain. Scale
bar = 500 |jm. (B) Zoom-in optical images of those tissue sections outlined in
(A). The circles highlight representative individual NPs embedded in the tissue
sections that were characterized. Scale bar = 50 pm. (C) LSPR spectra of those
single Ag-CALNNK (+) NPs circled in (B), with

at (a) 551 nm (green) (FWHM

= 111 nm) and (b) 532 nm (green) (FWHM = 98 nm).

77

SUMMARY
In this study we were able to design and characterize different charged
single Ag nanoparticle optical probes and follow their transport, diffusion, and
toxicity in early development of zebrafish embryos in real-time to effectively
monitor for an extended duration of time.

We determined that the different

charged nanoparticle optical probes could generate particular phenotypes in a
dose dependent and charge dependent manner. We also demonstrated that
negatively charged Ag nanoparticles exhibit more toxicity in the form of increased
deformities and death at the same concentrations as the positively charged Ag
nanoparticles.
The negative charge of the NPs definitely contributed to the toxicity during
the development of the embryo.

At the same concentrations of positively

charged Ag NPs, there were less overall deformities and less increase in death.
According to our findings, it appears that positively charged Ag NPs are more
biocompatible at higher concentrations; though the negatively charged Ag NPs
were found to be biocompatible at a low concentration (0.1 nM) it seems that
positive charged Ag NPs are more biologically compatible for a developing
organism. Recent studies investigating nanoparticle toxicity have demonstrated
that surface charge of the nanoparticle to be very significant in how a living
system responds to the nanoparticle especially related to proper distribution and
clearing from the body.72,

87"89

The results of our study indicate strong

concentration and charge dependence for Ag NP biocompatibility in developing
zebrafish embryos.
Previous studies have shown that surface charge determines if and how a
nanoparticle will get into cells.90 This is vital especially if looking at nanoparticles
for use as delivery vehicles because if it cannot move inside the cell successfully,
the drug or treatment will not be delivered.91 Additional studies have shown a
significant relationship between surface charge and the ability to generate ROS
causing inflammatory effects to living cells and tissues.92 A decrease in surface
charge of Ag NPs can be considered as one central characteristic, which could
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result in more toxicity.6 We determined from this experiment that our surface
charged Ag NPs were able to transport and diffuse into our in vivo model system
effectively without using any outside aid, for example, microinjection. It was
determined that the surface charged Ag NPs were able to diffuse into the chorion
via simple Brownian diffusion as we have observed in our previous studies.11
The deformities that we observed were finfold, tail flexure, cardiac
malformation, yolk sack edema, and eye malformation and these were
dependent on the concentration of the surface charged Ag NPs as well as the
charge. Recent studies using mice observed the similar toxicity findings and an
inability for the mice to clear negatively charged NPs from their systems.93"96 The
researchers found that negatively charged NPs in mice caused malformations
related to clogging of nanoparticles in organ systems93"95. It was also determined
that an increase in apoptosis was found to occur.96
It is possible that the negatively charged Ag NPs are interacting with
developmental pathways and interrupting dynamic events and causing several
different deformities at one time. Further studies are underway to determine the
cellular and molecular mechanisms involved in the toxicity.
In conclusion, we were able to determine that positive and negative
surface charged Ag NPs are able to transport, diffuse, and create toxic, as well
as non-toxic effects on our zebrafish embryos. We were also able to determine
that positively charged NPs are more biocompatible at higher concentrations
than negatively charged Ag NPs. It was also determined that zebrafish embryos
served as an effective in vivo model system, one that can be used to examine
different surface charges of nanoparticles and determine which surface charged
nanoparticles would be most biocompatible in a living system.
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METHODS
Synthesis and Characterization of Stability of Ag-CALNNK, Ag-CALNNS,
and Ag-CALNNE NPs
For Ag-CALNNK NPs, 50 ml of Ag NPs were synthesized as described
previously. After 45 minutes of stirring, PEG-20 was added to a final
concentration of 0.05% w/v under stirring. After 5 minutes of further stirring the
solution was filtered through a 0.22 pm filter39,97

2.5 ml of the Ag NPs with

PEG-20 was pipette into a 15 ml polypropylene tube. 10 such tubes were
prepared. To each tube 34 pi of 28 mM buffered CALNNK was added drop by
drop along the sides of the tube while vortexing the tube. The solution was then
mixed on a shaker for 12 hours at 4°C.
For Ag-CALNNS NPs, 50 ml of Ag NPs were synthesized as described
previously. After 45 minutes of stirring, PEG-20 was added to a final
concentration of 0.05% w/v under stirring. After 5 minutes of further stirring the
solution was filtered through a 0.22 pm filter39,97

2.5 ml of the Ag NPs with

PEG-20 was pipette into a 15 ml polypropylene tube. 10 such tubes were
prepared. To each tube 57 pi of 17 mM buffered CALNNS was added drop by
drop along the sides of the tube while vortexing the tube. The solution was then
mixed on a shaker for 12 hours at 4°C.

All three peptides were 0.5 mM

Phosphate buffer pH 7.0 with 1.5 mM NaCI.
For Ag-CALNNE NPs, Ag NPs were synthesized as described previously.
PEG-20 was added to a final concentration of 0.05% w/v under stirring. After 30
minutes of stirring the solution was filtered through a 0.22 pm filter39,97. 25 ml of
the Ag NPs with sodium citrate dihydrate and PEG-20 was kept stirring. To it 630
pi of 15 mM buffered CALNNE was added quickly. The solution was stirred at
room temperature for 1 hour and then mixed for 12 hours at 4°C.
The NPs were washed and characterized as described previously.
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Breeding and Monitoring of Zebrafish Embryos
We housed wild type adult zebrafish (Aquatic Ecosystems) in a stand
alone system (Aquatic Habitats) and maintained, bred, and observed them as
described previously.11,45

In Vivo Characterization and Analysis of Transport and Dose-Dependent
Biocompatibility and Toxicity of NPs
Cleavage-stage living embryos (8-64 cell stage; 0.75-2.25 hpf) incubated
with 0.2 nM NPs were characterized for transport and diffusion as described
previously.
To study the dose-dependent effects of NPs on embryonic development, a
dilution series of washed peptide-conjugated Ag NP solutions (0, 0.1, 0.2, 0.4,
and 0.6 nM) were incubated chronically with cleavage (8-cell) stage embryos in
egg-water for 120 hpf. Each experiment was carried out at least three times and
total number of embryos at 35-40 was studied for each individual concentration
to gain representative statistics. Nanoparticle concentrations were calculated as
described previously11. Embryo controls and observations were carried out as
described previously.

Characterization of NPs Embedded Inside Fully Developed Zebrafish
Characterization of the embedded peptide-conjugated Ag NPs (0.2 nM) in
the tissues of treated zebrafish, was done as described previously (Fig. 35).
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CHAPTER V
PROBING OF TRANSPORT, BIOCOMPATIBILITY AND TOXICITY OF SINGLE
42 NM SILVER NANOPARTICLES IN EARLY DEVELOPMENT OF
ZEBRAFISH EMBRYOS
INTRODUCTION
Nanoparticles have been increasingly used in consumer products, ranging
from cosmetics, toothpastes, socks, home appliances, water treatment, to
disinfection.98

Thus, it is crucial to study their potential nanotoxicity and

environment impacts.

Potential release of nanomaterials into aquatic

environments would lead to a direct impact on human health, due to human
consumption of fish and their ability to bioconcentrate trace contaminants from
environment. In previous chapters, we studied transport and effects of smaller
Ag NPs (11.6 ± 3.5 nm) on embryonic development and determined their
chemical-dependence.

In this study, we investigated the transportation and

effects of stable and purified medium-sized Ag NPs (41.6 ± 9.1 nm) on
embryonic development, aiming to better understand size-dependent transport
and toxicity of Ag NPs.

RESULTS AND DISCUSSION
Synthesis and Characterization of Stable and Purified Ag NPs
Ag NPs were synthesized, purified and characterized, as described in
Methods. Notably, highly purified Ag NPs were produced by thoroughly washing
Ag NPs with deionized (Dl) water to remove potential residual chemicals involved
in NP synthesis via centrifugation. The NPs were then suspended in egg-water
(1.0 mM NaCI, embryonic medium) for study of their stability and their effects on
embryonic development.
HRTEM images of single Ag NPs and histogram of their size distribution
(Figure 36A and B) show nearly spherical shaped NPs with average diameters of
41.6 ± 9.1 nm, ranging from 33 to 51 nm. Dark-field optical images of single Ag
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Figure 36. Characterization of stability and physicochemical properties of
Ag NPs suspended in egg-water. (A) HRTEM image show spherical shape of
single NPs.

(B) Histogram of size distribution of single NPs determined by

HRTEM show average diameters of 41.6 ±9.1 nm. (C) Dark-field optical image
of single NPs shows that majority of NPs are plasmonic green (D) LSPR spectra
of single NPs show Xmax (FWHM) at: (a) 458 (83); (b) 471 (75); (c) 543 (84); (d)
594 (90) nm. (E) Number of individual NPs measured over time using DFOMS
shows 131± 2, 131 ± 2, 134 ± 3, 134 ±4, 139 ± 5,133 ± 3 and 131 ± 4 per image
at 0, 12, 24, 48, 72, 96, and 120 h. (F) UV-Vis absorption spectra of NPs in (E):
(a) 0 and (b) 120 h show their peak absorbance at 0.87 with peak wavelength
(FWHM) at 418 (100) nm remain unchanged over time, showing high stability of
NPs in egg-water. Scale bars in (A) and (C) are 50 nm and 2 pm, respectively.
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NPs suspended in egg-water (Figure 36C) show single plasmonic green NPs as
majority with some blue and very few red NPs.

Localized surface plasmon

resonance (LSPR) spectra of representative single NPs (Figure 36D) show their
peak wavelengths (Amax) with full-width-of-half-maximum (FWHM) at 458 (83),
471 (75), 543 (84), and 594 (90) nm.
The stability (non-aggregation) of the purified NPs in egg-water were
characterized over the duration of embryonic development (120 h) at single-NP
resolution using DFOMS, UV-vis absorption spectroscopy and dynamic light
scattering (DLS).

The number of NPs dispersed in egg-water (Figure 36E)

remains unchanged over 120 h, indicating that NPs are stable (non-aggregated)
in egg-water. Absorbance of UV-vis spectra of NPs in egg-water (Figure 36F)
show that their absorbance of 0.87 with peak wavelength (FWHM) of 420 (100)
nm remain unchanged for 120 h. Size distributions of NPs measured by DLS
show their average diameters remain essentially unchanged at 45.5 ± 9.8 nm for
120 h. Note that NPs are solvated in egg-water, which leads to larger diameter
than those measured by HRTEM (Figure 36A, B). Taken together, these results
demonstrate that NPs are stable (non-aggregated) in egg-water over the entire
duration of embryonic development (120 h). Notably, contaminated unpurified
chemicals would have attributed to observable toxicity and unstable NPs in the
medium would lead to their size and dose changes over time, which had made
the study of nanotoxicity unreliable. Therefore, purified and stable nanomaterials
are essential for probing their size and dose dependent effects on living
organisms.

Real-Time Imaging of Transport of Single Ag NPs into/in Embryos
We studied diffusion and transport of single NPs in cleavage-stage embryos by
incubating NPs with the embryos and tracking their diffusion into and in embryos
in real time using DFOMS. We first focus on probing of entry of single NPs into
embryos from egg-water (outside chorion, OC) and then inside the embryos.

Optical images of the embryos (Figure 37) illustrate interface of egg-water with
chorionic space (CS) (chorionic layer, CL), CS, and interface of CS with inner
mass of embryos (IME), and transport of individual NPs through these interfaces
into IME. We found arrays of chorionic pore canals (CPCs) with diameters of
0.5-0.7 |jm and distances among nearby pores at 1.5-2.5 |jm on CL of the
embryos (Figure 37B) using DFOMS, which agree excellently with those
characterized using scanning electron microscopy (SEM).25

Individual NPs

diffused through chorionic pores to enter CS, then diffused in CS and finally
entered into IME (Figure 37B-D).
Notably, distinctive plasmonic optical properties (colors) of single Ag NPs
enable them to be distinguished from debris, embryonic cells and tissues. Sizedependent plasmonic properties of single NPs enable their sizes to be
determined using DFOMS via optical nano rulers, as we described previously.
The results show that single NPs with diameters of 33-51 nm can passively
diffuse into the embryos.
The diffusion modes of individual NPs were characterized as NPs were
diffusing into/in embryos by tracking diffusion trajectories of single NPs and
plotting real-time squared displacement (RTSD) versus diffusion time. Notably,
embryonic environments are highly heterogeneous and change over time, as
embryos develop. Thus, we used RTSD (diffusion distance at each time interval)
rather than mean-squared displacement (MSD) (average distance over time) to
investigate diffusion modes of single NPs.
Plots of RTSD versus time for single NPs that were diffusing through CPCs
into CS, in CS into IME, and IME show stepwise linearity, which suggests highly
heterogeneous embryonic environments. As described by diffusion theories,26"28
the linear plots indicate simple random Brownian motion and steps show
restricted diffusion, suggesting that passive diffusion of single NPs (but not active
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Figure 37. Real-time imaging of diffusion of single Ag NPs into single
cleavage-stage embryos. (A) Optical image of cleavage-stage embryo in eggwater. Chorionic layer (CL), chorionic space (CS), and the interface of the CS
with inner mass of embryo (IME) are squared as (B-D), respectively.

(B-D)

Sequential dark-field optical images of zoom-in squared areas in (A), show the
diffusion of single NPs (circle) from egg-water (outside chorion, OC) into CL, in
CS into IME, and within the IME. The time intervals between sequential images
in (B-D) are 1.1 s. See real-time Videos S1-3 in SI. Scale bars are 125 pm in (A)
and 20 pm in (B-D).

86

cellular signaling) enable them to enter embryos. Individual NPs were trapped
from time to time as they diffused from egg-water into CS and from CS to IME.
Interestingly, single NPs were trapped more often in IME, which was more
viscous than CS.
Diffusion coefficients (D) of single NPs were determined by dividing the
slopes of linear plots with four using two-dimensional (2D) Random walk theory
(RTSD = 4DAt). They are (5.0±1.0) x10"11, (4.9±3.0) x10"9, and (5.1±8.5) x10"10
cm2s"1 for single plasmonic green NPs going through CPCs from egg-water into
CS, in CS into IME, and in IME. Diffusion coefficients of the single NPs in eggwater measured using the same approaches are (5.2±1.8) x10"®cm2s"1.
Notably, diffusion coefficients of single NPs are inversely proportional to
viscosities of medium based upon Stokes-Einstein equation, D = kT/(6TTna),
where k is Boltzmann constant; T is temperature; a is radii of single NPs; and q is
viscosity of medium where NPs diffuse in. The results show that CL has the
highest viscosity and IME has higher viscosity than CS.

Embryonic

environments are orders of magnitude more viscous than egg-water. The large
standard deviations of diffusion coefficients of single NPs in embryos, especially
in IME,

show

high

heterogeneities

(viscosity

gradient)

of embryonic

environments. The results also demonstrate that single NPs can serve as optical
probes to study embryonic nanoenvironments.

Early-Development Embryos as Ultrasensitive In Vivo Assays
Optical images in Figure 38A show normal developmental stages of
zebrafish embryos, which includes cleavage (0.75-2.25 hours-post-fertilization,
hpf), gastrula (10 hpf), segmentation (24 hpf), and hatching stages (48 hpf), and
a fully developed zebrafish (120 hpf). All embryonic developmental stages of
zebrafish are well defined.
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Figure 38. Study of dose-dependent effects of Ag NPs on embryonic
development using embryos as ultrasensitive in vivo assays. (A) Optical
images of normally developing embryos at (a) cleavage-stage (0.75-2.25 hpf); (b)
late gastrula stage (10 hpf); (c) late segmentation stage (24 hpf); (d) hatching
stage (48 hpf); (e) fully developed larvae (120 hpf).

(B) Dead embryo. (C)

Histograms of distributions of embryos that developed to normal and deformed
zebrafish or became dead versus NP concentration. (D) Control experiments:
histograms of the distributions of embryos that developed to normal zebrafish or
became dead either in egg-water alone or versus concentration of supernatant,
which was collected from the last washing of NPs with Dl water. A total of 36
embryos were studied for each NP concentration and control in (C-D). Scale bar
is 500 |jm for all images in (A).
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The earlier developmental stage, such as cleavage stage, is likely more
prone and sensitive to the effects of external substances (e.g., drugs, NPs) than
later stages. Notably, the cleavage-stage embryos undergo drastic changes to
lay down foundation for developing different organs, and their related and
important developmental mechanisms remains not yet fully understood.16, 18,51
Thus, we select cleavage-stage embryos for study of transport, biocompatibility
and toxicity of NPs, aiming to develop ultrasensitive in vivo assays for effectively
screening of NPs and to rationally design biocompatible NP probes for in vivo
imaging.

Study of Dose and Size-Dependent Biocompatibility and Toxicity of Ag NPs
We studied dose-dependent toxic effects of NPs on embryonic development by
incubating cleavage-stage embryos with various concentrations (0-0.70 nM) of
colloid Ag NPs suspended in egg-waters for 120 h. Representative embryonic
developmental stages were imaged and assayed over time until the embryos
were fully developed. Number of embryos that developed to normal zebrafish
(Figure 38e), became dead (Figure 38B), and deformed zebrafish (Figure 39A)
were recorded.
The results in Figure 38C demonstrate high dependence of embryonic
development upon the NP concentrations, or doses.

As NP concentration

increases from 0 to 0.7, the number of embryos that developed to normal
zebrafish decreases, while the number of embryos that became dead increases.
Interestingly, the number of embryos that developed to deformed zebrafish
increases as NP concentration increases up to 0.2 nM.

However, none of

embryos survived beyond that, which is attributed to the decrease of deformed
zebrafish and the increase of dead embryos at NP concentration higher than 0.2
nM.
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Severe deformities (e.g., cardiac abnormalities, yolk sac edema, and
eye/head abnormalities) were observed at very low concentrations (< 0.2 nM), as
summarized in Figure 39A. For example, finfold deformities with disorganized
and improperly arranged finfolds (Figure 39A, a-b); abnormal tail flexing (spinal
cord) with nearly 180° bent (c-d); cardiac malformations (edema of the pericardial
sac region and cardiac arrhythmia) and Yolk sac edema with swollen and
enlarged yolk sac (e); and head edema and severe eye abnormalities with
micropthalmia (small eyes) and dissymmetric eyes (f-g), were observed at low
concentrations (< 0.2 nM).

These eye abnormalities were uncommon

deformations and rarely reported.

Notably, one severe deformation (e.g.,

cardiac, eye or head) observed in any given zebrafish was typically accompanied
with several other types of deformations (e.g., finfold, tail and yolk sac edema).
The results suggest that embryonic developmental pathways may be highly
regulated and one pathway may highly depend upon others.
Unlike our previous studies of smaller Ag NPs (11.6 ± 3.5 nm), more
embryos died and developed more severe deformed zebrafish at the lower
concentration, showing that the larger NPs are more toxic than smaller NPs.
Two control experiments were conducted simultaneously by incubating the
embryos with egg-water alone (blank control) and with the highest concentration
of supernatants collected from the last washing of NPs, which had been
thoroughly washed and stored in Dl water for at least five days.

The

supernatants were used to determine potential toxic effects of trace chemicals
(e.g., Ag+) results from NP synthesis or degradation over time, which serves as
control experiment to validate the observed toxicity in Figure 38C is attributed to
NPs, but not other chemicals. The results from control experiments for embryos
incubated with egg-water and the supernatants alone (Figure 38D) show that
over 95% of embryos developed to normal zebrafish, and no deformed zebrafish
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Dependence of types of deformed zebrafish on NP

concentration. (A) Optical images of deformed zebrafish show: (a-b) finfold
abnormalities; (c-d) tail/spinal cord flexure; (e) cardiac malformation and yolk sac
edema; and (f-g) eye abnormality. (B) Histograms of distributions of embryos
that developed to deformed zebrafish with five distinctive types of deformities at
NP concentration of 0.02, 0.05 and 0.10 nM. A total of 36 embryos were studied
for each NP concentration and control. Scale bar is 500 pm for all images in (A).
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were observed. Thus, the deformed zebrafish and high percent of dead embryos
observed in Figure 38C were attributed to NPs, but not contaminated chemicals.

Quantitative Characterization of Single Ag NPs Embedded in Zebrafish
To address why some embryos developed normally while others were
deformed or dead, we characterized single Ag NPs embedded in various tissues
of zebrafish, which had been incubated with NPs (< 0.2 nM) chronically for 120 h,
since they were cleavage-stage embryos. Longitudinal ultrathin sections (1-2 pm
thickness) of representative deformed zebrafish with all types of deformities show
NPs embedded in its eye (retina), brain, heart, and tail (Figure 40), as
characterized by distinctive LSPR spectra of individual NPs.

Interestingly,

transverse ultrathin sections of normally developed zebrafish also show NPs
embedded in the tissues similar to those of deformed zebrafish. The results
suggest that NPs diffused into embryos and stayed inside the embryos
throughout their entire development stages (Figure 41). The red shift of LSPR
spectra of individual NPs embedded in the tissues may be attributed to the
changes of their surrounding environments (e.g., dielectric constant of embedded
medium), which differ from egg-water.
The number of individual NPs embedded in eye (retina) and brain tissues
of normal and deformed zebrafish (Figure 42) shows that more plasmonic blue
and green (smaller) NPs were present in normal zebrafish, while more plasmonic
red (larger) NPs were found in deformed zebrafish. Note that size-dependent
plasmonic optical properties of single NPs enable us to determine their sizes in
situ in real time using single NP optical ruler, showing that the red NPs are the
largest NPs while the blue NPs are the smallest NPs. The results suggest that
larger NPs are more toxic than smaller NPs, further demonstrating sizedependent nano biocompatibility and toxicity.
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Figure 40. Characterization of individual Ag NPs embedded in deformed
zebrafish using DFOMS. (A) Optical image of ultrathin longitudinal section of
fixed zebrafish with five types of deformities. The rectangles highlight its (a)
retina (eye), (b) brain, (c) cardiac, and (d) tail. (B) Zoom-in optical images of the
tissue sections highlighted in (A) show embedded single NPs. (C) LSPR spectra
of the individual NPs circled in (B) show Xmax (FWHM) at: (a) 682 (87), (b) 552
(111), (c) 553 (94), and (d) 660 (106) nm. Scale bars are 500 pm in (A) and 50
pm in (B).
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Figure 41. Characterization of individual Ag NPs embedded in normally
developed zebrafish using DFOMS. (A)
transverse section of fixed zebrafish.

Optical

image

of

ultrathin

The dashed rectangles outline its (a)

retina, (b) lens, (c) forebrain, and (d) hindbrain tissues. (B) Zoom-in optical
images of the tissue sections highlighted in (A) show individual embedded NPs.
(C) LSPR spectra of representative single NPs circled in (B) show its A.max
(FWHM) at (a) 553 (113), (b) 559 (134), (c) 675 (70), and (d) 552 (106) nm.
Scale bars in (A-B) are 250 and 50 pm, respectively.
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Figure 42. Study of sizes and number of individual Ag NPs embedded in
both deformed and normal zebrafish. Histograms of the number and sizes
(colors) of single NPs embedded in: (A) eye (retina) and (B) brain tissues of
normally developed and deformed zebrafish.
deformed zebrafish each were analyzed.

Tissues of 15 normal and
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The results also suggest that individual embryos may respond to
nanotoxicity very differently.

Some embryos may be more tolerant to

nanotoxicity than others, underscoring the importance of study of biocompatibility
and toxicity of NPs at single embryo resolution. Random diffusion of single NPs
in embryos during their development may also play significant roles in creating
nanotoxiciy, emphasizing the importance of study of nano biocompatibility and
toxicity in real time at single NP resolution. Taken together, this study shows that
early-developmental stage embryos can serve as ultrasensitive in vivo assays for
effectively screening of biocompatibility and toxicity of NPs.

SUMMARY
In summary, we have designed, synthesized and characterized stable
(non-aggregated) and purified Ag NPs with average diameters of 41.6 ± 9.1 nm,
and developed DFOMS for imaging of single NPs in vivo in real time. We found
that individual NPs passively diffused into embryos through chorionic pores of
embryos, and stayed inside the embryos throughout the embryonic development.
Dose-dependent toxic effects of NPs on the embryonic development were
observed, showing that they were more biocompatible at lower doses and
became toxic at higher doses. As NP concentrations increase, the number of
embryos that developed to normal zebrafish decreases, while the number of
embryos that became dead increases. In comparison with our previous studies
of effects of smaller Ag NPs (11.6 ± 3.5 nm) on embryonic development, we
found striking size-dependent toxic effects of NPs on embryonic development.
Notably, larger NPs create higher toxic effects and more severe deformed
zebrafish at the lower concentration than smaller NPs. This study offers new
evidences of size-dependent nanotoxicity at single-NP resolution.
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METHODS
Synthesis and Characterization of Stable and Purified Ag NPs
Ag NPs (41.6 ± 9.1 nm in diameter) were synthesized by quickly adding
sodium citrate (10 mL, 34 mM) into a refluxing (100°C) AgN03 aqueous solution
(500 mL, 1.1 mM) under stirring. The mixture was refluxed and stirred for 45
min, as the solution color turned from colorless to straw yellow, then opaque and
finally muddy yellow. The heating was stopped and the solution was cooled
gradually to room temperature under stirring. The NP solution was filtered using
0.22-|jm filters.

All chemicals, except those indicated, were purchased from

Sigma and used as received.
The NPs were immediately washed three times as described previously.
Sizes and stability of NPs were characterized as described previously.

Breeding of Zebrafish Embryos
Wild-type adult zebrafish were maintained and bred as described
previously.

Real-time Tracking of Diffusion of Single Ag NPs into/in Embryos
The cleavage-stage embryos with egg-water were incubated with purified
NPs (0.2 nM) and transport and diffusion was characterized as described
previously.

Study of Dose-Dependent Biocompatibility and Toxicity of NPs and Control
Experiments
The cleavage-stage embryos in egg-water were incubated with a dilution
series of NPs (0, 0.02, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 0.7 nM) or (0, 5, 12, 24,
48, 95, 119, and 166 pg/mL) and supernatant control experiments were carried
out as described previously. Each experiment was carried out at least three
times and a total number of 36 embryos were studied for each NP concentration
and each control experiment to gain representative statistics and observations
were done as described previously.

Characterization of Single Ag NPs Embedded in Individual Zebrafish
We characterized individual NPs embedded in the tissues of zebrafish as
described previously (Figures 40-42).

Data Analysis and Statistics
A minimum of 100 Ag NPs was imaged and characterized for each
measurement of their sizes and stability in egg-water using HRTEM and DFOMS.
A minimum of 300 NPs in total was studied for each sample via three repeated
measurements. For real-time imaging of diffusion of single NPs into and in
embryos over time, a minimum of 15 embryos were studied for each given
concentration with 5 embryos for each measurement.

For study of dose-

dependent effects of NPs on embryonic development, a total number of 36
embryos were studied for each NP concentration and each control experiment
over 120 hpf with a minimum of 12 embryos studied in each measurement.
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CHAPTER VI
ASSAY OF TRANSPORT, BIOCOMPATIBILITY AND TOXCITY OF SINGLE 95
NM SILVER NANOPARTICLES USING ZEBRAFISH EMBRYOS

INTRODUCTION
Advances in nanotechnology demand rational design of biocompatible
nanomaterials and development of effective means and assays for well
characterization and rapid screening of biocompatibility and toxicity of
nanomaterials.

Engineered nanomaterials possess distinctive physiochemical

properties and promise wide ranges of applications from consumer products to
health care.98"101 In this study, we synthesized and purified larger Ag NPs with
average diameters of 95.4 ± 19.0 nm and used zebrafish embryos as in vivo
assays to study the transportation and effects of the NPs on embryonic
development.

We compared the results from this study with those from our

previous studies of transport and effects of smaller Ag (11.6 ± 3.5 nm) on
embryonic development, aiming to better understand size-dependent transport
and toxicity of Ag NPs.

RESULTS AND DISCUSSION
Synthesis and Characterization of 95 nm Ag NPs
We synthesized and purified Ag NPs as described in the Methods. TEM
images of purified single Ag NPs and their size distribution in Figure 43A and B
show oval NPs with average diameters of (95.4±19.0) nm. Representative darkfield optical image of single Ag NPs in Figure 43C show that majority of single
NPs exhibit plasmonic green color with a few being blue and red. Localized
surface plasmonic resonance (LSPR) spectra of representative single NPs show
peak wavelengths (Amax) at 478 nm with (full-width-of-half-maximum, FWHM, 78
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Figure 43. Characterization of sizes, shapes, and plasmonic optical
properties of single Ag NPs.
(A) Representative HRTEM image show the sizes, shapes and morphologies of
single Ag NPs. (B) Histogram of size distribution of single Ag NPs determined by
HRTEM shows their average diameters as 95.4±19.0 nm. (C) Representative
dark-field optical image of single Ag NPs shows individual plasmonic green,
yellow and red NPs. (D) LSPR spectra of single Ag NPs (green, yellow, and red)
show Amax (FWHM) at 558 (78), 610 (89) and 704 (91) nm, respectively. Scale
bars are 200 nm in (A) and 2 pm in (B).
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nm), 553 nm (FWHM, 89 nm), and 604 nm (FWHM, 91 nm), respectively (Figure
43D).

Size-dependent LSPR spectra of single NPs enable their sizes to be

determined in situ in real time at the nanometer (nm) scale using DFOMS, as we
reported previously.
We characterized the stability (non-aggregation) of the purified NPs
suspended in egg-water (embryonic medium) over 120 h at single NP resolution
using DFOMS. The number of single NPs in 60 images acquired by DFOMS
over 120 h remains essentially unchanged with around 133 NPs per image
(Figure 44A), suggesting that the NPs in egg-water are very stable. If NPs were
aggregated, the number of NPs in solution would have decreased and their sizes
would have increased over time, which would have made the study of dose and
size dependent toxic effects of NPs unreliable and irrelevant. Thus, it is crucial to
characterize the stability of NPs at single NP resolution in situ in real time. In this
study, DFOMS severs as a powerful tool to characterize the number and sizes of
single NPs in situ and in real time.
We

further

characterized

the

stability

of

NPs

using

ensemble

measurements, UV-vis spectroscopy and DLS. UV-vis spectra of the NPs in
egg-water over 120 h show their absorbance of 2.1 at 418 nm (FWHM, 100 nm)
and 1.9 at a shoulder peak of 392 nm (FWHM, 100 nm) remain unchanged
(Figure 44B).

Size distributions of NPs incubated in egg-water over 120 h,

measured by DLS (Figure 44C), show that their average diameters remain
essentially unchanged, ranging from 98.2±19.5 nm to 95.3±19.6 nm. The sizes
of hydrated NPs became slightly smaller after suspended in egg-water for 120 h,
which is likely attributed to the exchange of surface molecules (citrate ions) with
chloride ions in egg-water.

Similar phenomena were observed previously.

Taken together, the NPs are very stable (non- aggregation) in egg-water over
120 h (duration needed for embryos to fully develop), enabling us to investigate
their size and dose dependent transport into embryos and their effects on
embryonic development over time.
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Figure 44. Characterization of stability (non-aggregation) of Ag NPs in eggwater.
(A) The average numbers of single NPs per image acquired by DFOMS, for Ag
NPs (2 pM) incubated with egg-water 28°C for 0, 12, 24, 48, 72, 96, and 120 h,
are 133±2, 130±2, 135±3, 136±4, 135±3, 139±4 and 130±3, respectively. The
number of NPs remains essentially unchanged. Totally, 60 images are acquired
with 20 images per measurement at each time point, which allow single NP
measurements to gain sufficient statistics and represent bulk analysis.

(B)

Representative UV-Vis absorption spectra of Ag NPs (2 pM) incubated with eggwater at 28°C for (a) 0 and (b) 120 h shows the peak absorbances of 2.1 at 418
nm (FWHM = 100 nm) and 1.9 at 392 nm (FWHM = 76 nm). Both remain
unchanged over time for 120 h.
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Embryos as Ultrasensitive In Vivo Assays
Optical

images

of

zebrafish

embryos

show

their

well-defined

developmental stages, which include cleavage (0.75-2.25 hours-post-fertilization,
hpf), gastrula (10 hpf), segmentation (24 hpf), and hatching stages (48 hpf), and
a fully developed zebrafish (120 hpf).
The earlier developing embryos (cleavage-stage embryos) are highly
subjective to toxic effects of external substances. Therefore, they could serve as
more sensitive assays for screening of biocompatibility and toxicity of
nanomaterials than later stage embryos and fully developed fish. At cleavage
stage, the embryos undergo drastic changes to formulate the development of
different

organs

and

their

related

developmental

mechanisms

remain

unexplored.16,18,51 Thus, we chose cleavage-stage embryos as ultrasensitive in
vivo assays to study transport and toxicity of 90s-nm Ag NPs (Figures 45-47).

Entry of Single Ag NPs into Embryos and Diffusion Mechanisms
To determine whether 90s-nm Ag NPs can enter embryos and their
related transport mechanisms, we incubated NPs with cleavage stage embryos
and directly tracked diffusion of single NPs into and in embryos in real time using
DFOMS. The image of single live embryo in Figure 45A illustrates chorionic
layer (CL), chorionic space (CS) and inner mass of embryo (IME).

The

snapshots of sequential optical images (Figure 45B-D) show that single NPs
diffuse from egg-water into CS through chorionic pores (chorionic pore canals,
CPCs) on CLs; single NPs diffuse in CS, and diffuse from CS into IME,
respectively.

Arrays of chorionic pores on CLs were observed and their

diameters ranging from 0.5 to 0.7 pm were determined in vivo in real time using
DFOMS (Figure 3.6B). Interestingly, NPs diffused into embryonic cells on the
surface of IME were clearly visualized by DFOMS in real time (Figure 45D).
Notably, single Ag NPs exhibit distinctive plasmonic colors, which enable
them to be effectively distinguished from embryonic cells, membranes and debris
which appear white under dark-field illumination. Sizes of the single NPs were
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A
;"";D

Figure 45. Real-time probing of transport and diffusion of single Ag NPs
into/in embryos.
(A)

Optical image of the representative cleavage-stage embryo shows the

interfaces of chorionic layer (CL) with egg-water (outside chorion, OC), chorionic
space (CS), and the interface of CS with inner mass of embryos (IME) as
highlighted by (B), (C) and (D), where the transports of single Ag NPs are studied
in real time, respectively. (B-D) Sequential dark-field optical images of: (B) the
CL (as highlighted by dashed lines), (C) the interface of CS with IME (as marked
by dashed lines), and (D) IME, show the diffusion of single Ag NPs (as circled)
from outside the chorion (OC) in egg-water into the CL; in CS; and from CS into
IME, respectively. The time interval between each sequential image is 1.1 s.
Scale bars are 125 pm in (A) and 20 pm in (B-D).

104

*

1.0

2.0

C»(pM)
<3Normal >Ond

0%

0.0

'WhmIP^

2.0

Figure 46. Study of effects of Ag NPs on embryonic development. Optical
images in (A-C) show: (A) cleavage-stage embryos (0.75-2.25 hpf), which are
incubated with Ag NPs in egg-water for 120 h; and developed to (B) normal
zebrafish (120 hpf); or deformed zebrafish in Figure 5 or became (C) dead
embryo. Scale bars in (A-C) are 500 pm. (D) Histograms of percent distribution
of embryos that developed to normal or deformed zebrafish or became dead
show their dependence upon NP concentrations.

As NP concentration

increases, number of embryos developed to normal zebrafish decreases, while
the number of embryos that developed to deformed and became dead increases.
(E) Control experiments show the study of embryos incubated with supernatant
resulted from washing NPs (instead of NPs) in egg-water.

Histograms of

distributions of embryos that developed to normal zebrafish or became dead
show their independence on supernatant concentration. Over 90% of embryos
develop to normal zebrafish. No deformed zebrafish was observed.
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Figure 47. Study of dependence of types of zebrafish deformities upon NP
concentration.
(A) Representative optical images of deformed zebrafish show: (a-c) finfold
abnormalities; (b) tail/spinal cord flexure; (c, d) cardiac malformation and yolk sac
edema; and (d) eye abnormality.

Scale bar = 500 (jm.

(B) Histograms of

distributions of percent of embryos that developed to multiple types of deformed
zebrafish show their dependence upon NP concentration. As NP concentration
increases, the percent of embryos with severe deformities and various types of
deformities increase.
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determined in vivo in real time by their size-dependent LSPR spectra using
optical nano rulers as we described previously. The results in Figure 45 show
that single NPs with diameters of 95.4±19.0 nm diffused into embryos via
chorionic pores.
We further determined the diffusion mechanisms and modes (e.g., random
Brownian motion, directed or restricted diffusion) of single Ag NPs entry into the
embryos and inside the embryos using diffusion theories. Viscosities inside living
embryos vary greatly upon local embryonic environments, which alter over time
as embryos develop.

Thus, we used real-time square displacement (RTSD,

diffusion distance at each time interval) instead of mean-squared displacement
(MSD, average distance over time), to determine the diffusion modes and
diffusion coefficient of single NPs as they diffused into and through embryos.
Plots of RTSD of single NPs versus time show stepwise linearity, as
single NPs diffuse through chorionic pores, in CS, and into IME. As described in
diffusion theories, the linear plots of MSD versus time indicate simple random
Brownian motion and the steps show restricted diffusion.

Thus, the results

indicate that passive diffusion of single NPs (but not directed diffusion) enable
them to enter embryos. The plots show several steps, indicating that individual
NPs were frequently trapped in chorionic pores as they diffused from egg-water
into the embryos. Similar phenomena were observed as NPs diffused from CS
into IME, indicating dense interface of CS with IME.
We determined diffusion coefficients (D) of single NPs by dividing the
slopes of the linear plots with four using two-dimensional (2D) Random walk
theory (RTSD = 4DAt).28 They are (3.9±7.5) x10"11, (7.5±6.0) x10"9, and (7.8±8.2)
x10"10 cm2s"1 for single NPs going through CL into CS, in CS, and into IME.
Diffusion coefficients of the single NPs in egg-water measured using the same
approaches

are

(2.8±0.5)

xlO"8 cmV.

The results

suggest highly

heterogeneous embryonic environments and higher viscosity at IME and CL.
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Study of Dose and Size Dependent Toxicity of Ag NPs
To determine the dose-dependent toxicity of NPs, we incubated cleavagestage embryos with various concentrations (0-2.0 pM or 0-5.7 pg/mL) of purified
and stable Ag NPs 95.4±19.0 nm in egg-waters for 120 h, and imaged the
embryos as they developed in situ in real time.

This experimental design

enables NPs passively diffuse into embryos without intervention and the study of
their effects on embryonic development, which mimics the potential transport and
effects of NPs on aquatic and eco- living organisms should NPs release to the
environments.

We also conducted two types of control experiments

simultaneously by incubating the embryos with egg-water alone and with the
highest concentration of supernatants collected from the third washing of NPs to
determine effects of any potential residential chemicals from NP synthesis.
Embryos at representative development stages were imaged and
monitored over time for 120 h until the embryos were fully developed. Optical
images in Figures 46A-C and 47 show cleavage-stage embryos, normal
developed zebrafish, dead embryos, and deformed zebrafish, respectively. The
number of embryos that developed to normal and deformed zebrafish and
became dead was determined and plotted against concentrations of NPs and
supernatants. The results in Figure 46 show that embryonic development highly
depends upon NP concentration (dose). As NP concentration increases from 0
to 2.0 pM, the number of embryos that developed to normal zebrafish decreases,
while the number of embryos that developed to deformed zebrafish and became
dead increases.
In contrast, control experiments for embryos incubated with egg-water and
supernatants alone (in absence of NPs) show that over 95% embryos developed
to normal zebrafish and none of embryos developed to deformed zebrafish.
Therefore, the deformed zebrafish and dead embryos observed in Figures 46
and 47 were attributed to the NPs, but not residual chemicals from NP synthesis.

108

We examined individual morphological defects (phenotypes) of deformed
zebrafish and found various types of deformation, which includes abnormal
finfold and tail/spinal cord, cardiac malformation, yolk sac edema, and eye
deformities (Figure 47A).

The number of embryos developed to deformed

zebrafish with high severity and multiple deformities increases as NP
concentration increases (Figure 47B), showing dose-dependent phenotypes.
Finfold deformities (e.g., disorganized and improperly arranged finfolds)
and abnormal tail and spinal cord flexing (Figure 47A:ab) were observed in all
studied concentrations.

Note that normally developed zebrafish shows well

organized finfold rays and straight tails (spinal cord) (Figure 46B).
Interestingly, severe deformations, such as cardiac malformations (e.g.,
edema of the pericardial sac region and cardiac arrhythmia) and yolk sac edema
with swollen and enlarged yolk sac (Figure 47Ac) were observed only at higher
concentrations (s 1 pM). Deformed zebrafish with cardiac abnormalities quite
often also shows swollen and enlarged yolk sac (yolk sac edema). In normally
developed zebrafish (Figure 46B), the yolk sac (a bulbous area containing yolk
that provides nutrients to embryonic development) is much smaller because they
should shrink during later stages of embryonic development.24,

53, 86

Notably,

severe eye abnormalities and head edema were observed, starting at relatively
low concentrations (s 0.02 pM) and the number of deformed zebrafish with eye
abnormalities increases as NP concentration increases. Such eye abnormalities
were rarely observed for embryos that were exposed to smaller Ag NPs even at
high concentrations or toxic heavy ions (e.g., Cd2+).
Strikingly, individual zebrafish with one type of severe deformations (e.g.,
cardiac, eye or head) was typically accompanied with several other types of
deformations (e.g., finfold, tail and yolk sac edema) (Figure 47Ad).

Such

interesting findings suggest that embryonic developmental pathways are highly
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orchestra and one pathway likely highly depend upon others, which lead to
multiple deformations in single zebrafish.
By comparing the results of this study with those of our previous study of
effects of smaller Ag NPs (11.6±3.5 nm in diameter) on embryonic
development,11 we found that toxic effects of NPs highly depend upon their sizes.
Larger number of embryos developed to severe deformed zebrafish and became
dead as they were exposed to larger Ag NPs even at very low concentrations
(95.4±19.0 nm; £ 0.020 pM). In contrast, the embryos developed to normal
zebrafish, but not deformed zebrafish or became dead, as they were exposed to
small NPs even at higher concentrations (< 80 pM; 11.6±3.5 nm).11

Taken

together, the results show that the large NPs cause much higher toxic effects on
embryonic development than small NPs, and embryos can serve as effective in
vivo assays to screen biocompatibility and toxicity of NPs.
Quantitative Imaging and Analysis of Single Ag NPs Embedded in
Zebrafish
To address why some embryos developed normally while others became
deformed or dead, we further determined distributions of NPs in developed
zebrafish, which had been incubated with 90s-nm Ag NPs (£ 2 pM) chronically
for 120 h, since they were cleavage-stage embryos. Individual NPs embedded in
various tissues of normal and deformed zebrafish were characterized using
DFOMS.

The ultrathin sections (1-2 pm thickness) of tissue samples were

prepared as described in Methods. The results in Figure 48 show that NPs were
embedded in both normally developed and deformed zebrafish and NPs were
well distributed in eyes, hearts and brains of zebrafish, which indicates that NPs
diffused into embryos and stayed inside the embryos throughout their
developmental stages.
The number and sizes of individual Ag NPs embedded in tissues were
characterized using their distinctive plasmonic optical properties (colors), or size-
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Figure 48. Quantitative imaging of individual Ag NPs embedded in
deformed zebrafish using DFOMS.
(A) Optical image of longitudinal section of the fixed zebrafish with five types of
deformations show areas of: (a) eye, (b) cardiac and (c) brain tissues, as
squared in (a-c). (B) Zoom-in optical images of those tissue sections squared in
(A). Individual Ag NPs embedded in the tissue sections are circled. (C) LSPR
spectra of those single Ag NPs circled in (B) show distinctive Xmax (FWHM) of: (a)
556 (97), (b) 558 (101), and (c) 549 (104) nm. (D) Histograms of distributions of
the number of Ag NPs embedded in retina (eye) and brain of (a) normally
developed zebrafish and (b) deformed zebrafish show higher number of
embedded NPs in deformed NPs. The scale bars are 500 pm in (A) and 50 jjm
in (B).
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dependent LSPR spectras (Figures 48C). More NPs embedded in eye and brain
tissues were found in deformed zebrafish than normal zebrafish (Figure 48D),
suggesting dose-dependent toxic effects of NPs on embryonic development.
The larger number of NPs accumulated inside the embryos throughout their
development may lead to their deformation and dead. Nonetheless, individual
embryos could have various degrees of tolerance to toxic effects of Ag NPs.
Embryos with high degree of tolerance could survive and develop to normal
zebrafish, while those with low degree of tolerance could develop to deformed
zebrafish or become dead. Therefore, this study underscores the importance of
study of effects of NPs on embryonic development at single NP and single
embryo resolution.
SUMMARY
In summary, we have synthesized, purified and characterized Ag NPs
(95.4±19.0 nm) that are stable (non-aggregated) in egg-water (medium of
embryos; 1.5 mM NaCI) over the cause of entire embryonic development (120 h).
The results show individual NPs passively diffused into embryos through
chorionic pores, and stayed inside the embryos throughout entire embryonic
development, demonstrating their ability of concentrating potential release of NPs
into aquatic systems. NPs were observed in normal and deformed zebrafish that
had been incubated with NPs for 120 h since they were cleavage-stage embryos.
We found dose-dependent toxic effects of NPs on the embryonic development,
and higher doses of NPs led to higher levels of toxic effects on embryonic
development.

As NP concentrations increase, the number of embryos that

developed to normal zebrafish decreases, while the number of embryos that
became dead and developed to deformed zebrafish increases. In comparison
with our previous studies of effects of smaller Ag NPs (11.6 ± 3.5 nm in diameter)
on embryonic development, we found size-dependent toxic effects of NPs on
embryonic development and larger NPs are more toxic than smaller NPs. Taken
together, our studies show that zebrafish embryos can serve as ultrasensitive in
vivo assays to rapidly screen biocompatibility and toxicity of NPs and to
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effectively monitor the transport and effects of potential release of nanomaterials
into eco-systems.

METHODS
Synthesis and Characterization of 90s-nm Ag NPs
We synthesized Ag NPs (95.4±19.0 nm in diameter) by rapidly adding
sodium citrate (20 mL, 34 mM in Dl water) into AgN03 (500 mL, 1.06 mM in Dl
water) under stirring and refluxing. The mixture was continuously refluxed and
stirred for 95 min, while the colors of the mixture turned from colorless to straw
yellow, then opaque yellow, and finally muddy yellow. We then turned off the
heating mantle and continued refluxing and stirring the solution until it was cooled
to room temperature. The NP solution was immediately filtered using 0.22-jjm
filters and washed three times as described previously. The NP solution was
characterized for size and stability as described in previous chapters.

The

concentrations of colloidal NP solutions were calculated using the approaches as
we described previously.

Breeding of Zebrafish Embryos
Wild-type adult zebrafish (Aquatic Ecosystems) were maintained and bred
as described previously.

Real-time Imaging of Diffusion of Single Ag NPs into/in Embryos
The cleavage-stage embryos in self-made microchambers containing eggwater with purified and stable 90 nm Ag NPs (1 pM) were imaged in real-time to
track the diffusion of single NPs into embryos and inside embryos as we
described previously.
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Quantitative Study of Dose-Dependent Toxicity of Ag NPs
The cleavage-stage embryos were incubated with various concentrations
of 90 nm NPs (0, 2x10"\ 2x10 3, 1.0, and 2.0 pM) or (0, 5.7X10"4, 5.7X10"3, 2.8,
5.7 pg/mL) and supernatants as described in previous chapters.

Zebrafish

observations were done as described previously.

Quantitative Imaging of Single Ag NPs Embedded in Individual Zebrafish
The number and sizes of individual NPs embedded in the tissues of
interest were quantitatively determined using their size-dependent LSPR spectra
acquired by DFOMS and as described in previous chapters (Figure 48).

Data Analysis and Statistics
For study of sizes, shapes, LSPR spectra, and stability of single NPs, 300
individual NPs were studied for each sample with a minimum of 100 NPs for
each measurement.

For real-time imaging of transport and diffusion

mechanisms of single NPs into and in embryos over time, a minimum of 15
embryos were studied for each given concentration with 5 embryos per
measurement.

For study of dose-dependent effects of NPs on embryonic

development, a total number of 36 embryos were studied for each NP
concentration and each control experiment with a minimum of 12 embryos
studied per measurement.
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CHAPTER VII
CONCLUSION
In conclusion, as described in Chapter II, we utilized zebrafish embryos as
our living in vivo model system to assess the transport, biocompatibility, and
toxicity of our purified and biologically clean Ag NPs. By statistically comparing
the distributions of normal, deformed and dead embryos, it was observed that the
Ag NPs caused deformities and death in a concentration dependent manner.
The NPs were stable in the egg-water media and were found to transport into the
embryos by random diffusion. It was observed that the diffusion rates of the Ag
NPs varied dependent upon the area of the embryo in which they were
contained.

These results taken together implied that the NPs caused dose

specific deformity depending on the concentration of the nanoparticles and it was
determined that at a low dose the nanoparticles were biocompatible within the
embryonic system, causing no deformities.
In Chapter III, we utilized our in vivo model system used in chapter I, and
the same purified NPs to probe the stage dependent transport kinetics,
biocompatibility and toxicity effects of nanoparticles on embryos at different time
periods of development. The NPs were determined to enter and transport into
the embryos by random diffusion independent of the time of development. It was
observed that the Ag NPs caused deformities dependent on the concentration of
the nanoparticles, as well as the time period during development that the
nanoparticles were administered. These results taken together implied that the
NPs cause stage specific deformities depending on the time of development that
the nanoparticles were in contact with the embryo.
Apart from bare Ag NPs, in Chapter IV, Ag NPs, which were surface
conjugated with different peptides to yield different surface charges were also
used to probe the nanoenvironments within our in vivo model system in real time.
Using our state of the art DFOMS, we were able to observe Ag NPs inside the
embryo regardless of the surface charge of the NP. It was observed that the
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different surface charged Ag NPs caused deformities dependent not only on the
concentration of the nanoparticles, but dependent on the charge of the
nanoparticles. These results indicated that as the surface charge of the NP
became more positive; the NPs became more biocompatible, or less toxic,
causing fewer deformities.
Drug delivery vehicles will have molecules conjugated on the NP's surface
and it contributes to its charge on the surface, it was of interest to study the
surface charge of the NPs and how it would affect the transport and
biocompatibility of NPs in a living in vivo model system. These are important
considerations to be taken into account when designing drug delivery vehicles,
because they have to be able to transport in a living system to get where they
need to go to deliver a drug. This study is a significant step forward in that
direction by studying the transport kinetics inside a living system.
In the chapters II, III and IV, the stability of purified NPs in egg-water media
was comprehensively established before demonstrating the application of Ag
NPs as optical probes in our in vivo model system. In Chapter V we were also
able to establish the stability of our larger sized purified Ag NPs (42 nm) in eggwater media to utilize them in our in vivo model system to assay the transport,
biocompatibility and toxicity of larger sized nanoparticles on embryonic
development. We observed that the 42 nm Ag NPs were able to transport inside
the embryo by random diffusion and that the larger nanoparticles caused
deformities dependent on the concentration of the nanoparticles.

This was

similar to findings in chapter II, however it was found that the larger sized NPs
were much more toxic and less biocompatible at the same concentrations of the
12 nm Ag NPs. These results taken together imply that smaller sized NPs are
much more biocompatible as compared to larger sized 42 nm Ag NPs.
Apart from using the 42 nm Ag NPs, we also wanted to use a larger sized
Ag NP (95 nm) and explore their possible toxicity in our in vivo assay. In Chapter
VI we established the stability of our 95 nm purified Ag NPs in egg-water media
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and then used them to assay the transport, biocompatibility and toxicity on
embryonic development. We observed 95 nm Ag NPs inside the embryo and
were able to follow their transport into the embryonic mass despite their large
size and from this it was determined that the Ag NPs were able to transport
inside the embryo by random diffusion independent of the size. Deformities in
embryonic development were observed in a concentration dependent manner,
similar to findings in chapter II and V, however it was found that the 95 nm Ag
NPs were much more toxic and less biocompatible at even very low
concentrations in the pM range. These results taken together implied that the
smaller sized NPs, 12 nm - 42 nm, were much more biocompatible as compared
to the largest sized 95 nm Ag NPs.
The results of the research mentioned in this dissertation have
demonstrated that zebrafish embryos are a powerful in vivo model system to use
to assay the transport, biocompatibility, and toxicity of different types of
nanomaterials. This opens up the possibility of using this system as a standard
assay to screen many different types of multi-functional NPs, including targetspecific nanomaterials. There is the possibility of using NPs as effective drug
delivery vehicles by attaching desired drug molecules to the surface of NPs, so it
is very important to collect preliminary data on how a NP will transport in a living
system and if it will be toxic to living cells. To conclude, the chapters included in
this dissertation have shown conclusively the versatile nature of using zebrafish
embryos as an in vivo assay to screen different types of NPs by demonstrating
their use as a living embryonic model system to screen different types of Ag NPs.
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APPENDIX A
GUIDELINES FOR HANDLING NANOMATERIALS

Zebrafish Experiments
All experiments involving live zebrafish and/or zebrafish embryos and
nanoparticles were carried out in compliance with the guidelines set in IACUC
protocol #: 11-030 entitled "NIRT: Design of Biocompatible Nanoparticles for
Probing Living Cellular Functions and Their Potential Environmental Impacts"
and was approved April of 2012.
Handling Nanoparticles
According to NIOSH, the following workplace tasks may increase the risk
of exposure to nanoparticles:
1. Working with nanoparticles in liquid media without the necessary
protection (e.g., gloves, safety goggles) will increase the risk of skin or
eye exposure.
2. Working with nanoparticles in liquid media during pouring or mixing
procedures, or where high risk of agitation is involved, will lead to an
increased likelihood of inhalation of droplets, which may be formed.
3. Generating nanoparticles in the gas phase in non-enclosed systems
will increase the chances of aerosol release to the workplace.
4. Handling nano-structured powders will lead to the possibility of
aerosolization.
The following guidelines from the University of Oklahoma Health Sciences
Center were always followed when working with nanomaterials in the lab
(http://www.ouhsc.edu/ibc/documents/NanoparticleGuidelines.doc), although all
of these guidelines may not be applicable to the research work associated with
this dissertation.
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1. Lab coats were worn at all times.
2. Gloves were worn when handling nanoparticles. Because skin exposure
was a concern, gloves covered the hand and the wrist.
3. Long arm sleeves were required where high levels of exposure due to
splashes of solutions containing nanoparticles were anticipated.
4. Standard lab safety goggles were worn.
5. Whenever possible, work was performed in a chemical hood or biological
safety hood.
a. Aerosol producing activities (such as sonication, vortexing, or
centrifuging) were never conducted on an open lab bench.
b. Activities that were likely to release nanoparticles (such as opening
and emptying of tubes) were not performed on an open lab bench.
c. Solutions containing nanoparticles were handled over disposable
lab bench covers.
6. Hand washing facilities were provided in all labs. Hand washing was
performed after handling nanoparticles.
7. Lab bench tops and other surfaces had to be cleaned after each lab
experiment using a cleaning solution (methanol) suitable for the type of
nanoparticles being used.
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